CA2235619A1 - Modified plants and plant products - Google Patents
Modified plants and plant products Download PDFInfo
- Publication number
- CA2235619A1 CA2235619A1 CA002235619A CA2235619A CA2235619A1 CA 2235619 A1 CA2235619 A1 CA 2235619A1 CA 002235619 A CA002235619 A CA 002235619A CA 2235619 A CA2235619 A CA 2235619A CA 2235619 A1 CA2235619 A1 CA 2235619A1
- Authority
- CA
- Canada
- Prior art keywords
- alpha
- glucan
- cell
- plant
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920002472 Starch Polymers 0.000 claims abstract description 170
- 235000019698 starch Nutrition 0.000 claims abstract description 170
- 239000008107 starch Substances 0.000 claims abstract description 158
- 230000000694 effects Effects 0.000 claims abstract description 136
- 229920001503 Glucan Polymers 0.000 claims abstract description 104
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims abstract description 85
- 229920000945 Amylopectin Polymers 0.000 claims abstract description 79
- 108010004047 granule-bound starch synthase I Proteins 0.000 claims abstract description 67
- 210000004027 cell Anatomy 0.000 claims description 131
- 239000008187 granular material Substances 0.000 claims description 112
- 238000000034 method Methods 0.000 claims description 92
- 102000004190 Enzymes Human genes 0.000 claims description 77
- 108090000790 Enzymes Proteins 0.000 claims description 77
- 150000007523 nucleic acids Chemical class 0.000 claims description 36
- 108020004707 nucleic acids Proteins 0.000 claims description 35
- 102000039446 nucleic acids Human genes 0.000 claims description 35
- 238000003860 storage Methods 0.000 claims description 23
- 210000002706 plastid Anatomy 0.000 claims description 22
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 17
- 102000016679 alpha-Glucosidases Human genes 0.000 claims description 17
- 230000009466 transformation Effects 0.000 claims description 17
- 229920000642 polymer Polymers 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 12
- 239000013598 vector Substances 0.000 claims description 10
- 108010043943 Starch Phosphorylase Proteins 0.000 claims description 7
- 108700028369 Alleles Proteins 0.000 claims description 5
- 108010026867 Oligo-1,6-Glucosidase Proteins 0.000 claims description 5
- 230000004075 alteration Effects 0.000 claims description 5
- 108010043797 4-alpha-glucanotransferase Proteins 0.000 claims description 4
- 102400000471 Isomaltase Human genes 0.000 claims description 4
- 230000008685 targeting Effects 0.000 claims description 4
- 241000193411 Paenibacillus amylolyticus Species 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims 7
- 230000003247 decreasing effect Effects 0.000 claims 2
- 108010052221 glucan synthase Proteins 0.000 claims 2
- 230000001172 regenerating effect Effects 0.000 claims 2
- 230000000779 depleting effect Effects 0.000 claims 1
- 230000000644 propagated effect Effects 0.000 claims 1
- 230000001902 propagating effect Effects 0.000 claims 1
- 229920000856 Amylose Polymers 0.000 abstract description 69
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 241000196324 Embryophyta Species 0.000 description 115
- 108090000623 proteins and genes Proteins 0.000 description 61
- 229940088598 enzyme Drugs 0.000 description 54
- 235000010582 Pisum sativum Nutrition 0.000 description 49
- 230000015572 biosynthetic process Effects 0.000 description 46
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- 241000219843 Pisum Species 0.000 description 45
- 108010039811 Starch synthase Proteins 0.000 description 45
- 238000010348 incorporation Methods 0.000 description 44
- 238000003786 synthesis reaction Methods 0.000 description 44
- 210000002257 embryonic structure Anatomy 0.000 description 43
- 239000008103 glucose Substances 0.000 description 40
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 37
- 244000061456 Solanum tuberosum Species 0.000 description 37
- 235000002595 Solanum tuberosum Nutrition 0.000 description 35
- 239000000047 product Substances 0.000 description 33
- 229920001542 oligosaccharide Polymers 0.000 description 25
- 239000000284 extract Substances 0.000 description 24
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 23
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 22
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 22
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 22
- WFPZSXYXPSUOPY-ROYWQJLOSA-N ADP alpha-D-glucoside Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-N 0.000 description 21
- 238000011534 incubation Methods 0.000 description 21
- 239000006228 supernatant Substances 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 18
- 210000000056 organ Anatomy 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000007792 addition Methods 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 229920002684 Sepharose Polymers 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- 239000008188 pellet Substances 0.000 description 14
- 108010029485 Protein Isoforms Proteins 0.000 description 13
- 102000001708 Protein Isoforms Human genes 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 12
- 238000003556 assay Methods 0.000 description 12
- 230000014509 gene expression Effects 0.000 description 12
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 11
- 241000589158 Agrobacterium Species 0.000 description 11
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 108010028688 Isoamylase Proteins 0.000 description 9
- 238000010828 elution Methods 0.000 description 9
- 235000012015 potatoes Nutrition 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000004587 chromatography analysis Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 239000004382 Amylase Substances 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 101100020212 Mus musculus Klhdc3 gene Proteins 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 240000004713 Pisum sativum Species 0.000 description 5
- 150000001413 amino acids Chemical group 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000000692 anti-sense effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000004570 mortar (masonry) Substances 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 229920001592 potato starch Polymers 0.000 description 5
- 239000013615 primer Substances 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 4
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 description 4
- OCIBBXPLUVYKCH-QXVNYKTNSA-N alpha-maltohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-QXVNYKTNSA-N 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 244000038559 crop plants Species 0.000 description 4
- 239000000287 crude extract Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 235000009973 maize Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- DJMVHSOAUQHPSN-UHFFFAOYSA-N malto-hexaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(OC4C(C(O)C(O)C(CO)O4)O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 DJMVHSOAUQHPSN-UHFFFAOYSA-N 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- 238000011426 transformation method Methods 0.000 description 3
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 3
- 108020005544 Antisense RNA Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- 101710091688 Patatin Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 2
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 229940025131 amylases Drugs 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 239000007998 bicine buffer Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229960004261 cefotaxime Drugs 0.000 description 2
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000003413 degradative effect Effects 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000005567 liquid scintillation counting Methods 0.000 description 2
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 2
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 238000004161 plant tissue culture Methods 0.000 description 2
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000013324 preserved food Nutrition 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000002195 soluble material Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 108090000344 1,4-alpha-Glucan Branching Enzyme Proteins 0.000 description 1
- 102000003925 1,4-alpha-Glucan Branching Enzyme Human genes 0.000 description 1
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical class O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000219318 Amaranthus Species 0.000 description 1
- 108010033764 Amylosucrase Proteins 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 108010001483 Glycogen Synthase Proteins 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 102100027918 Sucrase-isomaltase, intestinal Human genes 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000010675 chips/crisps Nutrition 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- AXZAYXJCENRGIM-UHFFFAOYSA-J dipotassium;tetrabromoplatinum(2-) Chemical compound [K+].[K+].[Br-].[Br-].[Br-].[Br-].[Pt+2] AXZAYXJCENRGIM-UHFFFAOYSA-J 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000011094 fiberboard Substances 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229950010772 glucose-1-phosphate Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000005272 metallurgy Methods 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- -1 phosphinotricin Chemical compound 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910001487 potassium perchlorate Inorganic materials 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013595 supernatant sample Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Malto-oligosaccharide (MOS) content of cells (particularly plants cells) is modulated, resulting in alterated .alpha.-glucan (e.g. starch) production by the cells. Granule Bound Starch Synthase I (GBSSI) activity in production of unbranched .alpha.-glucan, such as amylose, and branched .alpha.-glucan, such as amylopectin, is modified by modulating MOS content.
Description
CA 0223~619 1998-04-22 W O 97/165~4 PCT/GB96/02696 MODIFIED PLANTS AND PLANT PRODUCTS
The present invention relates to plant modification, particularly modification via the manipulation of activity of a plant enzyme "GBSSI" an ~-glucan synthase to alter the nature of starch an ~-glucan produced by the plant. GBSSI activity is modulated by controlling malto-oligosaccharide content, found to be required for amylose (an unbranched ~-1,4 glucan with few or no ~-1,6 linkages) synthesis by GBSSI. When the availability of malto-oligosaccharides to GBSSI is reduced the enzyme extends amylopectin (a branched ~-1,4, ~-1,6 glucan) instead of amylose.
Starch granules from storage organs such as cereal endosperms, potato tubers and pea embryos contain two or more distinct iso~orms of starch synthase. All have a highly-conserved, exclusively granule-bound isoform of about 60 kDa - usually the major granule-bound protein - which will be referred to as granule-bound starch synthase I (GBSSI), and one or more other isoforms. Analysis of mutants lacking GBSSI has shown that this isoform is specifically required for the synthesis of amylose, the relatively unbranched glucan polymer which comprises approximately 30% by weight of the starches o~ wild-type storage organs (Smith and Martin 1993). Thus, it is accepted that GBSSI (also known as "the waxy protein") is responsible for synthesis o~ the amylose CA 0223~619 1998-04-22 W'097/16554 PCT/GB96/02696 component of starch (evidence reviewed in Smith and Martin 1993, Smith et al. 1995, Martin and Smith 1995)-The function of the GBSSs other than those of the GBSSI class has not been established. It is clear from studies of starches of mutants that lack GBSSI
that these other isoforms cannot synthesise amylose to any significant extent (eg Denyer et al. 1995a, Hylton et al. 1995). However, it is not known whether these isoforms contribute to the synthesis of amylopectin within the granule. Some of the GBSSs other than GBSSI, such as the 77-kDa GBSS of developing pea embryos (referred to as GBSSII), are found in the soluble fraction of the amyloplast as well as being associated with starch granules (Denyer et al. 1993).
Such isoforms are very likely to be involved in amylopectin synthesis when soluble, and may become trapped within the matrix of the granule as it grows.
Other GBSSs appear to be predominantly if not entirely associated with starch granules, such as the 100-105-kDa GBSS of developing wheat endosperm (Denyer et al.
1995b). Thus, at present there is no evidence to suggest that the other GBSSs do participate in the synthesis of amylose (Hylton et al. 1995, Denyer et al. 1995a). Amylose synthesis may be an exclusive property of the waxy protein.
In spite of this widely accepted hypothesis, no-one has demonstrated amylose synthesis by an isolated CA 0223~619 1998-04-22 starch granule from a higher plant. It has been established that glucose from ADPglucose (ADPG) is readily incorporated into the starch of storage organs of crop plants when ADPG is supplied to isolated starch granules (eg. Frydman and Cardini 1967, Macdonald and Preiss 1983, Smith 1990, Hylton et al.
1995, Denyer et al. 1995b). However, this incorporation is into a amylopectin and not an amylose (Baba et al. 1987).
The present invention is based on the surprising discovery that glucan of low molecular weight (malto-oligosaccharides: referred to as MOS) present in vivo but apparently not in isolated starch granules is required for amylose synthesis by GBSSI. Without malto-oligosaccharide GBSSI extends amylopectin, not amylose.
Evidence for this is described in detail herein, but to summarise:
1. Isolated starch granules from developing embryo of pea and developing potato tuber incorporate glucose from ADPG mainly into branched ~-glucan chains. Very little glucose is incorporated into amylose.
The present invention relates to plant modification, particularly modification via the manipulation of activity of a plant enzyme "GBSSI" an ~-glucan synthase to alter the nature of starch an ~-glucan produced by the plant. GBSSI activity is modulated by controlling malto-oligosaccharide content, found to be required for amylose (an unbranched ~-1,4 glucan with few or no ~-1,6 linkages) synthesis by GBSSI. When the availability of malto-oligosaccharides to GBSSI is reduced the enzyme extends amylopectin (a branched ~-1,4, ~-1,6 glucan) instead of amylose.
Starch granules from storage organs such as cereal endosperms, potato tubers and pea embryos contain two or more distinct iso~orms of starch synthase. All have a highly-conserved, exclusively granule-bound isoform of about 60 kDa - usually the major granule-bound protein - which will be referred to as granule-bound starch synthase I (GBSSI), and one or more other isoforms. Analysis of mutants lacking GBSSI has shown that this isoform is specifically required for the synthesis of amylose, the relatively unbranched glucan polymer which comprises approximately 30% by weight of the starches o~ wild-type storage organs (Smith and Martin 1993). Thus, it is accepted that GBSSI (also known as "the waxy protein") is responsible for synthesis o~ the amylose CA 0223~619 1998-04-22 W'097/16554 PCT/GB96/02696 component of starch (evidence reviewed in Smith and Martin 1993, Smith et al. 1995, Martin and Smith 1995)-The function of the GBSSs other than those of the GBSSI class has not been established. It is clear from studies of starches of mutants that lack GBSSI
that these other isoforms cannot synthesise amylose to any significant extent (eg Denyer et al. 1995a, Hylton et al. 1995). However, it is not known whether these isoforms contribute to the synthesis of amylopectin within the granule. Some of the GBSSs other than GBSSI, such as the 77-kDa GBSS of developing pea embryos (referred to as GBSSII), are found in the soluble fraction of the amyloplast as well as being associated with starch granules (Denyer et al. 1993).
Such isoforms are very likely to be involved in amylopectin synthesis when soluble, and may become trapped within the matrix of the granule as it grows.
Other GBSSs appear to be predominantly if not entirely associated with starch granules, such as the 100-105-kDa GBSS of developing wheat endosperm (Denyer et al.
1995b). Thus, at present there is no evidence to suggest that the other GBSSs do participate in the synthesis of amylose (Hylton et al. 1995, Denyer et al. 1995a). Amylose synthesis may be an exclusive property of the waxy protein.
In spite of this widely accepted hypothesis, no-one has demonstrated amylose synthesis by an isolated CA 0223~619 1998-04-22 starch granule from a higher plant. It has been established that glucose from ADPglucose (ADPG) is readily incorporated into the starch of storage organs of crop plants when ADPG is supplied to isolated starch granules (eg. Frydman and Cardini 1967, Macdonald and Preiss 1983, Smith 1990, Hylton et al.
1995, Denyer et al. 1995b). However, this incorporation is into a amylopectin and not an amylose (Baba et al. 1987).
The present invention is based on the surprising discovery that glucan of low molecular weight (malto-oligosaccharides: referred to as MOS) present in vivo but apparently not in isolated starch granules is required for amylose synthesis by GBSSI. Without malto-oligosaccharide GBSSI extends amylopectin, not amylose.
Evidence for this is described in detail herein, but to summarise:
1. Isolated starch granules from developing embryo of pea and developing potato tuber incorporate glucose from ADPG mainly into branched ~-glucan chains. Very little glucose is incorporated into amylose.
2. Both the GBSSI and other GBSS isoforms contribute to this synthesis of amylopectin. Starch granules isolated from the developing embryos of mutant peas which completely lack GBSSI protein and amylose, but retain a second GBSS isoform, (lam -CA 0223~619 1998-04-22 W~97/16554 PCT/GB96/02696 mutant: Denyer et al 1995a) incorporate glucose from ADPG into amylopectin, but at a much lower rate on a starch basis than starch from wild-type peas. This indicates that a considerable proportion of the amylopectin synthesis by isolated starch granules from wild-type pea embryos is via GBSSI.
3. Addition of MOS to isolated starch granules of wild-type pea embryos and potato tubers causes an increase in the amount and a substantial shift in the pattern of incorporation of glucose from ADPG.
Incorporation into amylopectin is reduced, and incorporation into lower molecular weight material of the same mobility as amylose on gel-permeation columns is substantially increased. MOS ranging from maltose (G2) to malto-heptaose (G7) have been shown to cause this shift. Glucose does not have this effect.
Incorporation into amylopectin is reduced, and incorporation into lower molecular weight material of the same mobility as amylose on gel-permeation columns is substantially increased. MOS ranging from maltose (G2) to malto-heptaose (G7) have been shown to cause this shift. Glucose does not have this effect.
4. The synthesis of amylose from ADPG in the presence of MOS is exclusively a function of GBSSI.
MOS had no effect on the incorporation of glucose from ADPG into isolated starch granules of the lam mutant that lacks GBSSI: incorporation was into amylopectin whether MOS were present or not.
MOS had no effect on the incorporation of glucose from ADPG into isolated starch granules of the lam mutant that lacks GBSSI: incorporation was into amylopectin whether MOS were present or not.
5. Extracts of the storage organs of higher plants contain compounds that mimic the effect of MOS
on the incorporation of glucose from ADPG into isolated starch granules. When ADPG is supplied to a homogenate of pea or potatoes, glucose is incorporated into both amylopectin and amylose within the granules CA 0223~619 1998-04-22 in the homogenate. Rapid washing of granules from the homogenate to remove soluble components of the homogenate lowers the total rate of incorporation of glucose from ADPG, and results in loss of ~ 5 incorporation into amylose. Addition of the heat-stable soluble fraction of the homogenate to isolated granules promotes incorporation of glucose from ADPG
and causes a shift from amylopectin towards amylose synthesis, in the same manner as the addition of MOS.
on the incorporation of glucose from ADPG into isolated starch granules. When ADPG is supplied to a homogenate of pea or potatoes, glucose is incorporated into both amylopectin and amylose within the granules CA 0223~619 1998-04-22 in the homogenate. Rapid washing of granules from the homogenate to remove soluble components of the homogenate lowers the total rate of incorporation of glucose from ADPG, and results in loss of ~ 5 incorporation into amylose. Addition of the heat-stable soluble fraction of the homogenate to isolated granules promotes incorporation of glucose from ADPG
and causes a shift from amylopectin towards amylose synthesis, in the same manner as the addition of MOS.
6. The compounds in plant extracts that mimic the effects of MOS are themselves MOS. Incubation of the heat-stable soluble fraction of homogenates ~f potato tuber with ~-glucosidase - an enzyme that will specifically convert MOS to glucose - destroys the ability of this fraction to stimulate incorporation of glucose from ADPG into isolated starch granules, and to redirect synthesis from amylose to amylopectin.
The results indicate that the presence of MOS in the amyloplast in vivo is a prerequisite for the synthesis of amylose via GBSSI and that GBSSI activity is redirected from amylose to amylopectin in the absence of MOS. Accordingly, the present inventors have realised that manipulation of MOS levels in planta provides a means for manipulation of starch produced by the plant, in particular the nature of the amylopectin component of the starch.
The implications and applications of this work CA 0223~619 1998-04-22 are many-fold. Manipulation of the level of MOS in amyloplasts of the storage organ of a plant will affect amylose synthesis by GBSSI and action of GBSSI
on chains of amylopectin. Accordingly, the properties of the starch produced by the plant will be modified.
There is considerable interest in modifying starch and creating and investigating novel properties. Starch is of major interest in many industries, including the food, paper, oil, glue, tobacco and textile industries. For instance, starch, modified or otherwise, is used in beer, animal feeds, baking products such as biscuits, doughnuts, pies, crisps, in canned foods such as soups, fruits and vegetables, in cereals, in condiments such as ketchup, in fats and oils such as margarine, in dried foods, syrups and sweeteners, in a whole host of other foods, in building materials such as cardboard, ceramics, fiberboard and fiberglass, paints, in numerous chemical products and processes, in crayons-and chalk, cord, string, in metallurgy, explosives, rubber, textiles, dyes and in tobacco. Potato starch, for example, is used for sizing and surface coating in the paper industry, in sizing of cotton, worsted and spun rayon wraps, and in finishing sewing thread and cloth in the textile industry.
"Waxy corn", in which the starch is composed entirely of amylopectin (a branched ~-glucan) as compared with 72 percent amylopectin and 28 percent CA 0223~619 1998-04-22 amylose (an unbranched ~-glucan) in common corn starch. Several alleles have been observed at the waxy locus. See, for example, "CORN - Improvement, Seed Production and Uses", Jugenheimer (1976), John Wiley & Sons, USA, for a discussion.
A group including Visser at the Agricultural University and CPRO Institute in Wageningen, The Netherlands, have used anti-sense technology targeting waxy protein expression to produce a waxy starch potato. This work was commissioned by the paper industry, providing further illustration of the interest in starch modification and its importance.
According to a first aspect of the present invention there is provided a method comprising modulating the amount of malto-oligosaccharide (MOS) present in a plant cell. Specifically amyloplasts of a storage organ of a plant are of interest. Altering the level of malto-oligosaccharide in the cell affects GBSSI production of amylose and amylopectin thereby influencing the nature of the starch produced.
In one embodiment of the present invention, malto-oligosaccharide in the cell is depleted. Any mechanism that reduces or eliminates MOS from amyloplasts of a developing storage organ prevents or ~ 25 reduces amylose synthesis by GBSSI. GBSSI action upon the chains of amylopectin in the granule is concomitantly increased. This results in a starch which lacks or has reduced levels of amylose, and has CA 0223~619 1998-04-22 an amylopectin structure that is different from that of both wild-type starches and the starch of mutant and transgenic plants which lack or have very low levels of GBSSI (for example the waxy mutants of maize, barley, sorghum rice and Amaranthus, the amf mutant of potato, the lam mutant of pea, and transgenic potatoes expressing an antisense construct containing any GBSSI sequence: specific literature references in Smith and Martin 1993) and may be different from that of wild-type starch. The amylopectin of plants which lack or have very low levels of MOS should have longer branches than amylopectin from wild-type plants or plants with altered levels of GBSSI of the same species, and may have longer branches than the amylopectin from wild-type plants of the same species.
Thus an aspect of the present invention provides a method of modifying amylopectin produced in a plant cell (or a method of producing modified amylopectin in a plant cell), the method comprising modulating the amount of malto-oligosaccharide (MOS) in the cell.
Altering the MOS level within the cell affects the action of GBSSI, and thus alters the amylose and amylopectin contents of the cell. In preferred embodiments, MOS is depleted (wholly (which includes substantially wholly) or partially) within the cell, leading to modified amylopectin production. The use of a substance which reduces the level of malto-CA 0223~619 1998-04-22 W O 97tl6554 PCT/GB96/02696 oligosaccharide in a plant cell in modifying starch produced in the cell (especially the amylopectin component of the starch) is provided as a further aspect of the present invention.
~ 5 The level of MOS in a plant cell may be assessed quantitatively by the following method. First, the metabolism of the cell is stopped by extremely rapidly. Typically, the tissue is clamped in tongs cooled to the temperature of liquid nitrogen, then 10 allowed to thaw in 1 M perchloric acid. A soluble extract of the tissue at neutral pH suitable for enzymic assay of metabolites is then prepared. In the example above, the perchloric acid extract of the tissue is brought to neutrality with a suitable 15 alkaline solution such as 5 M potassium carbonate, and the resulting insoluble potassium perchlorate is removed by centrifugation. The extract is incubated with enzymes and other factors required to remove sucrose and glucose. This may be achieved, for 20 example, by the addition of invertase, glucose 6-phosphate dehydrogenasei adenosine triphosphate, nicotinamide adenine dinucleotide, and magnesium chloride at appropriate concentrations as described by Lowry and Passonneau (1971). The extract is then A 25 incubated with an excess of ~-glucosidase and ~-amyloglucosidase to hydrolyse MOS to glucose, and the glucose is assayed for example as described by Lowry and Passonneau (1971). The amount and nature of the CA 0223~619 1998-04-22 MOS in a tissue may be investigated by several methods utilising a fraction containing soluble neutral compounds obtained from an extact (prepared as described above) by ion-exchange chromatography.
These methods include thin-layer chromatography, paper chromatography, and high-performance anion-exchange chromatography with pulsed amperometric detection.
Partial or total elimination of MOS in an amyloplast may be achieved using an enzyme that uses MOS as a substrate, converting it into something else.
For example, suitable enzymes convert MOS to glucose.
One way of providing such an enzyme, or other substance that reduces MOS availability to GBSSI, to a plant cell is by expression within the cell of an encoding nucleic acid sequence. A preferred enzyme for this purpose is an ~-glucosidase (EC 3.2.1.20), which may have a strong maltase activity (ie a low Km for maltose) and possibly little or no isomaltase activity (ie little or no action on ~-1,6 linkages) or activity with starch granules. Obviously, it is preferred that the enzyme has a pH optimum within the range of pH likely to occur within the cytoplasm of the cell (typically 6.5-7.8).
Enzymes with such activity may be identified by their ability to hydrolyse the specific substrate 4-nitropenyl glucoside, as described by Needleman et al.
(1978). Incubation of the enzyme at an appropriate pH
and with a suitable concentration of the substrate CA 0223~619 1998-04-22 results in the appearance of a yellow colour as hydrolysis proceeds.
The Km for maltose or any other MOS may be defined by the incubation of the enzyme at a suitable pH with a range of concentrations of maltose or other MOS for a defined period over which the reaction has been established to proceed linearly. Measurement of the amount of glucose produced over the defined period by any suitably specific and sensitive means (for example by enzymic assay as described by Lowry and Passonneau, 1971) then provides a quantitative estimate of enzyme activity from which the affinity of the enzyme for its substrate may be calculated by any of the methods described for this purpose by Cornish-Bowden (1995).
The pH optimum of the enzyme may be discovered byincubation of the enzyme with a suitable substrate at a range of different pH (typically a range from 5.5 to 8.5) followed by measurement of the amount of substrate hydrolysed at each pH. The action of the enzyme upon starch may be examined by the measurement of the production of reducing sugars upon incubation of the enzyme with starch granules, or with solubilised polymers derived therefrom. A suitable method for the measurement of reducing sugars is described by Bernfeld (1951).
All of the above methods may be applied to purified or partially purified enzymes obtained from a -CA 0223~619 1998-04-22 WO 97/16~54 PCT/GB96/02696 commercial source or by purification or partial purification from any appropriate organism. Methods of purification are exemplified by that described for yeast by Needleman et al. (1978). The techniques described above may also be used to study enzymes in cell extracts prepared from any suitable organism.
However, any person skilled in the art will appreciate that cell extracts may contain several activities capable of the hydrolysis of MOS and/or starch, and definition of the properties of any one of these activities may not be possible without partial purification.
The maltase of the bacterium Bacillus amylolyticus and the maltase encoded at the M~l6 locus of the yeast Saccharomyces carlsbergensis are suitable (Kelly and Fogarty 1983): the gene for the Saccharomyces maltase has been cloned (Hong and Marmur 1986).
As necessary, any person skilled in the art may clone the gene for any desired maltase from a bacterium by, for example, an obvious modification of the E. coli transformation method used to clone an oligo-1,6-glucosidase from Bacillus cereus (Watanabe et al. 1990) or by complementation of a Saccharomyces strain carrying mutations in structural genes for maltase and thus unable to utilise maltose as a carbon source (Federoff et al. 1982). The efficacy of ~-glucosidase in destroying plant MOS that promote CA 0223~619 1998-04-22 W O 97/16~54 PCT/GB96/02696 amylose synthesis, thus allowing amylopectin synthesis rather than amylose synthesis by GBSSI, is demonstrated by experiments described in detail herein.
Genes may be cloned using in~ormation from sequences available in databases known to those skilled in the art. A method o~ obtaining nucleic acid may comprise hybridisation of an oligonucleotide or a nucleic acid molecule comprising such an oligonucleotide to target/candidate nucleic acid.
Target or candidate nucleic acid may, ~or example, comprise a genomic or cDNA library obtainable ~rom an organism known to contain or suspected of containing such nucleic acid. Success~ul hybridisation may be identified and target/candidate nucleic acid isolated for further investigation and/or use.
Hybridisation may involve probing nucleic acid and identifying positive hybridisation under suitably stringent conditions (in accordance with known techniques) and/or use o~ oligonucleotides as primers in a method o~ nucleic acid ampli~ication, such as PCR. For probing, pre~erred conditions are those which are stringent enough for there to be a simple pattern with a small number o~ hybridisations ldenti~ied as positive which can be investigated ~urther. It is well known in the art to increase stringency o~ hybridisation gradually until only a ~ew positive clones remain.
CA 0223~619 1998-04-22 U'O 97/16554 PCT/GB96/02696 1~
As an alternative to probing, though still employing nucleic acid hybridisation, oligonucleotides designed to amplify D~A sequences may be used in PCR
reactions or other methods involving amplification of nucleic acid, using routine procedures. See for instance "PCR protocolsi A Guide to Methods and Applications", Eds. Innis et al, 1990, Academic Press, New York.
On the basis of amino acid sequence information oligonucleotide probes or primers may be designed, taking into account the degeneracy of the genetic code, and, where appropriate, codon usage of the organism from the candidate nucleic acid is derived.
An oligonucleotide for use in nucleic acid amplification or probing may have about 10 or fewer codons (e.g. 6, 7 or 8), i.e is about 30 or fewer nucleotides in length (e.g. 18, 21 or 24).
Assessment of whether or not such a PCR product corresponds to the gene of interest may be conducted in various ways. A PCR band ~rom such a reaction might contain a complex mix of products. Individual products may be cloned and each one individually screened. It may be analysed by transformation to assess function on introduction into a plant of interest.
Nucleotide sequences employed in the present invention may encode a wild-type sequence (e.g. gene) selected from those available, or a mutant, CA 0223~6l9 l998-04-22 derivative, variant or allele, by way of insertion, addition, deletion or substitution of one or more nucleotides, of such a sequence. An alteration to or difference in a nucleotide sequence may or may not be reflected in a change in encoded amino acid sequence, depending on the degeneracy of the genetic code. In any case, mutants, derivatives and alleles useful in the present invention are those which retain a functional characteristic of the polypeptide encoded by the wild-type gene, i.e. maltase activity as discussed. Of course, changes to the nucleic acid which make no difference to the encoded amino acid sequence~are included.
The nucleic acid may be in the form of a recombinant vector, for example a plasmid or agrobacterium binary vector (Van den Elzen et al., 1985). The nucleic acid may be under the control of an appropriate promoter and regulatory elements for expression in a plant cell. In the case of genomic DNA, this may contain its own promoter and regulatory elements and in the case of cDNA this may be under the control of an appropriate promoter and regulatory elements for expression in the host cell.
Those skilled in the art are well able to construct vectors and design protocols for recombinant gene expression. Suitable vectors can be chosen or constructed, containing appropriate regulatory sequences, including promoter sequences, terminator CA 0223~619 1998-04-22 ~tO 97/16554 PCT/GB96/02696 fragments, polyadenylation sequences, enhancer sequences, marker genes and other se~uences as appropriate. For further details see, for example, Molecular Cloning: a Laboratory Manual: 2nd edition, Sambrook et al, 1989, Cold Spring Harbor Laboratory Press. Many known techniques and protocols for manipulation of nucleic acid, for example in preparation of nucleic acid constructs, mutagenesis, sequencing, introduction of DNA into cells and gene expression, and analysis of proteins, are described in detail in Short Protocols in Molecular Biology, Second Edition, Ausubel et al. eds., John Wiley & Sons, 1992.
The disclosures of Sambrook et al. and Ausubel et al.
are incorporated herein by reference. Specific procedures and vectors previously used with wide success upon plants are described by Beran (1984) and Guerineau and Mullineaux (1993).
Selectable genetic markers may be used consisting of chimaeric genes that confer selectable phenotypes such as resistance to antibiotics such as kanamycin, hygromycin, phosphinotricin, chlorsulfuron, methotrexate, gentamycin, spectinomycin, imidazolinones and glyphosate (Herrera-Estrella et al, 1983; van den Elzen et al, 1985).
Introduction or elevation of activity of ~-glucosidase into amyloplasts of the developing storage organs of crop plants may be achieved using any appropriate method of plant transformation to generate CA 0223~619 1998-04-22 plant cells comprising nucleic acid with a sequence encoding the enzyme. Plants may be regenerated from transformed plant cells and tissue.
For example, potato may be transformed by incubation of tuber slices with Agrobacterium cells carrying the gene of interest and a gene encoding resistance to kanamycin in a suitable construct (Spychalla and Bevan, 1993). After co-cultivation for two days on tobacco feeder layers, discs are transferred onto Murashige and Skoog (MS) medium containing cefotaxime to select against Agrobacterium, then transferred to agar plates containing MS medium, cefotaxime, and kanamycin to select for growth of transformed cells. Shoots are excised from the discs and subcultured twice on MS medium containing kanamycin before transfer to soil.
When introducing a chosen gene construct into a cell, certain considerations must be taken into account, well known to those skilled in the art. The nucleic acid to be inserted should be assembled within a construct which contains effective regulatory elements which will drive transcription. There must be available a method of transporting the construct into the cell. Once the construct is within the cell membrane, integration into the endogenous chromosomal material either will or will not occur. Finally, as far as plants are concerned the target cell type must be such that cells can be regenerated into whole CA 0223~619 1998-04-22 plants.
Plants transformed with the DNA segment containing the sequence may be produced by standard tec~niques which are already known for the genetic manipulation of plants. DNA can be transformed into plant cells using any suitable technology, such as a disarmed Ti-plasmid vector carried by Agrobacterium exploiting its natural gene transfer ability (EP-A-270355, EP-A-0116718, NAR 12(22) 8711 - 87215 1984), particle or microprojectile bombardment (US 5100792, EP-A-444882, EP-A-434616) microinjection (WO 92/09696, WO 94/00583, EP 331083, EP 175966, Green et al. (1987) Plant Tissue and Cell Cul ture, Academic Press), electroporation (EP 290395, WO 8706614 Gelvin Debeyser - see attached) other forms of direct DNA uptake (DE
4005152, WO 9012096, US 4684611), liposome mediated DNA uptake (e.g. Freeman et al. Plant Cell Physiol.
29: 1353 (1984)), or the vortexing method (e.g.
Kindle, PNAS U.S.A. 87: 1228 (199Od) Physical methods for the transformation of plant cells are reviewed in Oard, 1991, Biotech. Adv. 9: 1-11.
Agrobacterium transformation is widely used by those skilled in the art to transform dicotyledonous species. Recently, there has been substantial progress towards the routine production of stable, fertile transgenic plants in almost all economically relevant monocot plants (Toriyama, et al. (1988) Bio/Technology 6, 1072-1074; Zhang, et al. (1988) CA 0223~619 1998-04-22 Plant Cell Rep. 7, 379-384; Zhang, et al. (1988) Theor Appl Genet 76, 835-840; Shimamoto, et al. (1989) Nature 338, 274-276; Datta, et al. (1990) Bio/Technology 8, 736-740; Christou, et al. (1991) Blo/Technology 9, 957-962; Peng, et al. (1991) International Rice Research Institute, Manila, Philippines 563-574; Cao, et al. (1992) Plant Cell Rep. 11, 585-591; Li, et al. (1993) Plant Cell Rep.
12, 250-255; Rathore, et al. (1993) Plant Molecular 10 Biology 21, 871-884; Fromm, et al. (1990) Bio/Technology 8, 833-839; Gordon-Kamm, et al. (1990) Plant Cell 2, 603-618; D'Halluin, et al. (1992). Plant Cell 4, 1495-1505; Walters, et al. (1992) Plant Molecular Biology 18, 189-200; Koziel, et al. (1993) 15 Biotechnology 11, 194-200; Vasil, I. K. (1994) Plant Molecular Biology 25, 925-937; Weeks, et al. (1993) Plant Physiology 102, 1077-1084, Somers, et al. (1992) Bio/Technology 10, 1589-1594; WO92/14828). In particular, Agrobacterium mediated transformation is now emerging also as an highly efficient alternative transformation method in monocots (Hiei et al. ~l994?
The Plant Journal 6, 271-282).
The generation o~ fertile transgenic plants has been achieved in the cereals rice, maize, wheat, oat, and barley (reviewed in Shimamoto, K. (1994) Current Opinion in Biotechnology 5, 158-162.; Vasil, et al (1992) Bio/Technology 10, 667-674; Vain et al., 1995, Biotechnology Advances 13 (4): 653-671; Vasil, 1996, CA 0223~619 1998-04-22 Nature Biotechnology 14 page 702).
Microprojectile bombardment, electroporation and direct DNA uptake are preferred where Agrobacterium is inefficient or ineffective. Alternatively, a combination of different techniques may be employed to enhance the e~ficiency of the trans~ormation process, eg bombardment with Agrobacterium coated microparticles (EP-A-486234) or microprojectile bombardment to induce wounding followed by co-cultivation with Agrobacterium (EP-A-486233).
Following transformation, a plant may be regenerated, e.g. from single cells, callus tissue or leaf discs, as is standard in the art. Almost any plant can be entirely regenerated from cells, tissues and organs of the plant. Available techniques are reviewd in Vasil et al., Cell Culture and Somatic Cel Genetics of Plants, Vol I, II and III, Laboratory Procedures and Their Applications, Academic Press, 1984, and Weissbach and Weissbach, Methods for Plant Molecular Biology, Academic Press, 1989.
The particular choice of a transformation technology will be determined by its efficiency to transform certain plant species as well as the experience and preference of the person practising the invention with a particular methodology of choice. It will be apparent to the skilled person that the particular choice of a trans~ormation system to introduce nucleic acid into plant cells is not CA 0223~619 1998-04-22 essential to or a limitation of the invention, nor is the choice of technique for plant regeneration.
A suitable method for transforming potatoes such that the product of the introduced gene may be targeted to amyloplasts is exemplified by the work of Shewmaker et al. (1994). A plasmid pCGN1132S contains a 35S promoter, a transit peptide and 16 amino acids of the mature protein of the pea ribulose bisphosphate carboxylase small subunit gene. The gene encoding the enzyme of interest is cloned into the plasmid as an in-frame fusion with the 16 amino acids of the small subunit. The fusion gene is excised and cloned into the patatin promoter cassette pCGN2162. A DNA segment containing the 700-base pair patatin promoter, the transit peptide, the 16 amino acids of the small subunit, the gene of interest and a 300-base pair nos 3' region is excised and cloned into the binary vector pCGN1557. This plasmid is then transferred to Agrobacterium tumefaciens strain LBA4404 and used to 2 0 transform potatoes. The efficacy of this method for achieving targeting of proteins to amyloplasts is illustrated by immunoblots which show correct processing of the expressed protein in potato tubers.
The ability of the method to bring about alterations - 25 of starch structure in potatoes is illustrated by its use to introduce a gene encoding a bacterial glycogen synthase (Shewmaker et al., 1994) The amylopectin of transformed plants had fewer longer branches and more shorter branches than control plants.
A second method which may be used to target an ~-glucosidase to the amyloplasts of the storage organs of crop plants is exemplified by the work of Klosgen and Weil (1991). In a procedure similar to that described above, these workers fused DNA encoding the transit peptide and 34 amino acids of the mature waxy protein of maize to the gene encoding the ~-glucuronidase of ~. col i . Introduction of the construct into potato plants via an Agrobacterium based method led to expression of the fusion protein in chloroplasts and amyloplasts of the transgenic plants.
Levels of MOS in a cells may be reduced via a reduction within that cell in the activity of one or more of the endogenous enzymes capable of generating MOS. Such enzymes, and methods for their identification and the cloning of genes that encode them, are discussed elsewhere herein. Reductions in activity may be achieved by the introduction into the cell of a gene - or part thereof - in the antisense orientation, such that an antisense RNA is produced within the cell. The gene or part thereof will encode the endogenous enzyme or another enzyme sufficiently similar in sequence to the gene encoding the endogenous enzyme. The introduction of the gene may be achieved by any suitable transformation method, as discussed elsewhere herein. Development and use of CA 0223~619 1998-04-22 constructs containing genes in the antisense orientation to bring about a reduction in an enzyme activity is exemplified by the work of Edwards et al.
(1995)and Marshall et al. (1996), who employed this technology to bring about large reductions in specific forms of starch synthase within the potato plant.
A further aspect of the invention provides a starch-producing cell of a plant, the level of malto-oligosaccharide in the cell being reduced comparedwith the level in an equivalent wild-type cell and the starch having an increased or modified amylopectin component compared with the starch produced by the equivalent wild-type cell. Preferably, the level of malto-oligosaccharide is reduced by virtue of expression within the cell of a polypeptide with maltase activity (as disclosed) from heterologous encoding nucleic acid therefor.
The term "heterologous" indicates that the gene/sequence of nucleotides in question has been introduced into cells of the plant or an ancestor thereof, using genetic engineering, i.e. by human intervention. The gene may be on an extra-genomic vector or incorporated, preferably stably, into the 2 5 genome.
The cell may comprise the nucleic acid encoding the enzyme by virtue of introduction into the cell or an ancestor thereo~ of the nucleic acid, e.g. by _ CA 0223~619 1998-04-22 W ~ 97/16554 PCT/GB96/02696 transformation, using any suitable technique available to those skilled in the art. Furthermore, plants which comprise such cells, and seed therefor, may be produced by crossing suitable parents to create a hybrid whose genome contains the required nucleic acid, in accordance with any available plant breeding technique.
Also according to the invention there is provided a starch-producing plant cell as disclosed having incorporated into its genome a sequence of nucleotides encoding a polypeptide with maltase activity under operative control of-a regulatory sequence for expression of the encoded polypeptide. Expression of the polypeptide results in depletion of malto-oligosaccharides in the cell, which in turn results inaction of GBSSI on amylopectin as opposed to amylose to produce modified amylopectin. A further aspect of the present invention provides a method of making such a plant cell involving introduction of a vector comprising the sequence of nucleotides into a plant cell. Such introduction may be followed by recombination between the vector and the plant cell genome to introduce the sequence of nucleotides into the genome. The polypeptide encoded by the introduced nucleic acid may then be expressed in the cell and descendants thereof, including cells in plants regenerated from transformed material. A gene stably incorporated into the genome of a plant is passed from _ CA 0223~619 1998-04-22 generation to generation to descendants of the plant, so such decendants should show the desired phenotype.
The present invention also provides a plant comprising a plant cell as disclosed. Such a plant produces modified amylopectin and starch as disclosed.
A plant according to the present invention may be one which does not breed true in one or more properties.
Plant varieties may be excluded, particularly registrable plant varieties according to Plant Breeders' Rights. It is noted that a plant need not be considered a "plant variety" simply because it contains stably within its genome a transgene, introduced into a cell o~ the plant or an ancestor thereof.
In addition to a plant, the present invention provides any clone of such a plant, seed, selfed or hybrid progeny and descendants, and any part of any of these, such as cuttings, seed. The invention provides any plant propagule, that is any part which may be used in reproduction or propagation, sexual or asexual, including cuttings, seed and so on.
The present lnvention is particularly beneficial for use in plants such as crop plants, including cereals and pulses, maize, wheat, potatoes, tapioca, rice, sorgum, millet, cassava, barley, pea and other root, tuber or seed crops, in principle any plant which is a source of starch.
The amylopectin and/or starch may be extracted CA 0223~619 1998-04-22 W O 97/16~54 PCT/GB96/02696 from plants according to the invention following its production in cells of the plant. Starch and/or amylopectin may be obtained using any available tecnique. For instance, potato starch is easily separated from tubers and in early nineteenth-century households was commonly prepared for domestic use. On an industrial scale, starch may be obtained from potatoes using, for example, a method along the following lines: The potatoes are disintegrated in a stream of water in a rapidly rotating vertical hammer-mill enclosed by a cylindrical perforated screen.
Through this the pulp is forced and passes into a series of centrifugal rotating sieves. The starch suspension which has passed through the sieves proceeds, with the addition of wash water, through a number of centrifugal separators to remove soluble impurities, then through a vacuum filter, a preliminary conveyor-drier with a countercurrent of air at about 145 ~C, followed by a series of blowers with cyclone separators, also at 145 ~C, and a final cool-air blower with cyclone.
A further aspect of the present invention thus provides starch or amylopectin obtained or obtainable from a plant or plant cell according to the invention as disclosed.
The starch or amylopectin removed from a plant may be purified and may be formulated into a composition. A composition containing such starch or CA 0223~619 1998-04-22 amylopectin may include one or more, i.e. at least one, additional component. Such compositions include food formulations, industrial formulations etc. Uses of starches and compositions containing starch have been discussed above.
"Malto-oligosaccharide" includes individually or collectively any ~-1,4 or ~-1,4,~1,6 glucan that is soluble within the cell rather than forming part of a polymer within the starch granule, including each of the mono- and oligomers investigated experimentally herein, such as maltose, maltotriose, maltotetraose, maltopentaose, maltohexaose and/or maltoheptaose.
Reference to malto-oligosaccharide "content" is to composition (quality) and/or level (quantity).
It should be noted that terms such as "modulating" and "altering" are used in relation to control being exercised over something as a result of human intervention. With respect to the level of MOS
in a cell, the intervention may result in an increase or decrease in the level of MOS as compared with the level in the absence of the intervention, i.e. in comparison with equivalent wild-type cells, e.g. of plants of the same species. (Cells which are wild-type in respect of MOS levels may of course not be wild-type in every respect.) Instead of modulating the level of MOS in a cell by way of reduction or depletion, the level may be increased in order to direct action of GBSSI from CAW O 97/16~54 PCT/GB96/02696 amylopectin to amylose.
Any mechanism that increases the concentration o~
MOS in the amyloplast of developing storage organs may bring about an increased synthesis of amylose by increasing the availability of primer for GBSSI
activity or the affinity of GBSSI for amylose relative to amylopectin within the starch granule. This results in an increased ratio of amylose to amylopectin in the starch, and may also af-fect the size and/or structure of amylose molecules. An increased concentration of MOS may be brought about by the introduction into the amyloplast of any enzyme capable of the generation of MOS.
These glucans can be generated in vivo by several enzymes known to be present in developing starch-storing organs, namely ~-amylase, ~-amylase, disproportionating enzyme, debranching enzyme and starch phosphorylase. Glucans can also be generated by other enzymes, including debranching enzymes, starch phosphorylases and amylosucrases of bacteria.
The first four of these enzymes can generate glucans by cleavage or rearrangement of nascent glucan chains synthesised by starch synthase and starch-branching enzyme. Starch phosphorylase can generate glucans ~rom glucose 1-phosphate (Steup 1988, 1990; Takaha et al. 1993).
Typically preferred enzymes for use in this aspect of the invention have low or negligible -CA 0223~619 1998-04-22 activity against intact starch granules, and may be a starch phosphorylase or a ~-amylase. Obviously, a pH
optimum within the range of pH likely to occur within the all cytoplasm (typically 6.5-7.8) is preferred.
Methods for identification and characterisation of activities of these enzymes are extensively discussed by Steup (1990). Genes for plastidial isoforms of phosphorylase, ~-amylases, ~-amylases, disproportionating enzymes and debranching enzymes have been cloned (Nakano et al. 1989, Lin et al. 1991, Sonnewald et al. 1995, Yoshida et al. 1992, Siggens 1987, Monroe et al. 1991, Kreiss et al. 1987, Takaha et al., 1993, James et al. 1995~. DNA sequences of these enzymes are described in the references cited above and in databases, and may be used to clone genes encoding these and further enzymes, for instance using methods described above for ~-glucosidases. The activity in the amyloplast of a storage organ may be increased by introduction of one of these genes by any appropriate method of plant transformation, as discussed.
For instance, this may be achieved by the Agrobacterium rhizogenes-based method used by van der Lei3 et al (1991) for the successful introduction of the amf gene product into the amyloplast of potato tubers carrying a mutation at the amf locus. The gene used for transformation should preferably be from a species different from that being transformed, to CA 0223~619 1998W O 97/16554 PCT/GB96/02696 . 30 avoid potential problems of co-suppression. Genes for B-amylase have been cloned from plants and bacteria (eg. Yoshida et al. 1992, Siggens 1987, Monroe et al.
1991, Kreiss et al. 1987) hence this activity may be introduced into the amyloplast of a storage organ through the use of any of these genes in any appropriate method of plant transformation. The products of these genes are typically targeted to cell compartments other than the plastid in plants, and outside the cell in bacteria. Preparation of a suitable construct for introduction of B-amylase activity into the amyloplast advantageously may therefore involve selection of a part of the protein that has catalytic activity but lacks targeting sequences. Information about the structure-function relationships of the protein enables a person skilled in the art to select such a region of the protein (eg.
Janacek 1994, Kawazu et al. 1987). Construction and int-roduction of an appropriate plasmid for expression of a B-amylase in the amyloplast may be achieved using any suitable technique available to the person skilled in the art, as discussed above e.g. for ~-glucosidase.
Thus, the present invention relates to increasing the level of MOS in a plant cell in various aspects which are analogous to those disclosed and discussed above in relation to reducing MOS levels.
Activity of a glucan-synthesizing enzyme in a cell or tissue extract or enzyme within a purified CA 0223~619 1998-04-22 starch granule may be identified by ability of the enzyme, extract or granule to incorporate the glucosyl moiety from ADPG into a glucan via an ~-1,4 linkage.
The preferred methods of assay are described by Jenner et al. (1994).
Modification of the activity or nature of the granule bound starch synthase activity of a cell may be used to alter the extent or the nature of the change in starch stucture brought about by alteration of MOS content in the cell.
Genes encoding GBSSI from many plant species have been cloned (see Ainsworth et al., 1993), and sequences are available. DNA sequences may be used by a person skilled in the art to clone a GBSSI gene from any suitable species using suitable methods, e.g. as discussed above.
These sequences may be introduced into a plant in such a way as to increase or decrease or alter the nature of the granule-bound starch synthase activity via any suitable transformation technology, again discussed above. Increases may be brought about by introduction of a gene encoding the endogenous enzyme.
Decreases may be brought about through introduction of the gene encoding the endogenous enzyme in an antisense orientation. Alteration of the nature of the enzyme may be brought about by the introduction of a gene encoding a GBSSI or a similar protein from another species, or a gene that has been subjected to CA 0223~619 1998-04-22 ~'O 97/16554 PCT/GB96/02696 mutation such that the properties of the GBSSI it encodes have been modified. A modified GBSSI or a GBSSI from another species may be introduced into a wild-type plant such that the introduced protein is synthesised in addition to the endogenous GBSSI, or it may be introduced into a cell in which endogenous GBSSI activity has been reduced or eliminated through mutation of the expression of antisense RNA.
The present invention will now be illustrated and exemplified with reference to experimental results and the accompanying figures. Further aspects and embodiments of the present invention, and modifications of those disclosed herein, will be apparent to those skilled in the art.
T~E FIGURES:
Figure la: Elution of solubilised pea starch from a column of Sepharose CL-2B. ~ = absorbance at 595 nm of fractions mixed with iodine. ~ = wavelength of maximum absorbance of fractions mixed with iodine Figure lb: Elution of 14C from a column of Sepharose CL-2B loaded with the methanol/KCl-insoluble products of incubation of isolated starch granules from pea embryos with ADP[U-14C]glucose. ~ =
incubation for 1 h. ~ = incubation for 0 h (control).
dps: disintegrations per second.
Figure 2: Effect of debranching with isoamylase CA 0223~619 1998-04-22 on elution profile of 14C from a column of Sepharose CL-2B. Two samples of isolated starch granules from pea embryos were incubated with ADP[U-14C]glucose for 1 h. Methanol/KCl-insoluble products were then incubated with isoamylase (~), or not treated further (--) Figure 3: Comparison of the incorporation of 14C
into methanol/KCl-insoluble products after incubation of starch from wild-type embryos (-) and lam mutant embryos (n) with ADP[U-14C]glucose for 1 h.
Figure 4: Comparison of the granule-bound proteins of wild-type and lam mutant pea embryos.
Starch granules were boiled in SDS-containing sample buffer and centrifuged, and the supernatant was subjected to SDS-polyacrylamide gel electrophoresis as described by Smith (1990). Tracks 1 and 8 = molecular weight markers (sizes indicated in kDa). Tracks 2-4 =
starch from embryos from three different pods of wild-type peas. Tracks 5-7 = starch from embryos from three different pods of lam mutant peas. tracks 2-7 all contain protein from the same weight of starch.
Figure 5: Effect of heat-stable soluble compounds from plant extracts on incorporation of 14C
from ADP[U-14C]glucose by starch granules. Freshly 25 harvested pea embryos (250-350 mg) were homogenised in a mortar in 100 mM Mops (pH 7.2), 5 mM MgCl2, 50 ml.1~
glycerol, 2 mM DTT, 1 g 1-l bovine serum albumin The homogenate was either used directly (unwashed starch CA 0223~619 1998-04-22 granules) or 1-ml aliquots o~ the homogenate were centrifuged at 10000 g for 5 min to give a supernatant containing soluble material and a pellet containing starch granules. The supernatant was removed and the pellet was washed three times by resuspension in homogenisation medium, followed by centrifugation at 10000 g for 5 min and then resuspended in homogenisation medium to give a final volume of 1 ml.
Samples of washed (-) and unwashed (O) starch granules were incubated for 1 h with ADP[U-l4C]glucose and the methanol/KCl-insoluble products were subjected to Sepharose CL-2B chromatography.
Figure 6: Effect of ~-glucosidase treatment on the stimulatory effect of soluble extract on amylose synthesis. Isolated starch granules and treated and untreated supernatant ~ractions were those described in Table 2. The products of assays of granules suspended in Mops medium (-), treated supernatant (O) and untreated supernatant (O) were subjected to chromatography on Sepharose CL-2B
Figure 7: Effect of malto-oligosaccharides on incorporation of 14C from ADP[U-l4C]glucose into methanol/KCl-insoluble products by starch granules from wild-type pea embryos. Incubations were for 1 h and contained 100 mM maltose (O), 100 mM maltotriose (o) 100 mM maltohexaose (x) or no additions (-).
Figure 8: Comparison of the effects of maltotriose on incorporation of 14C from ADP[U-CA 0223~619 1998-04-22 14C]glucose by starch granules from wild-type pea embryos (O = with maltotriose, ~ = without maltotriose) and lam mutant pea embryos (O = with maltotriose, ~ = without maltotriose) Figure 9: Effect of malto-oligosaccharides on incorporation of 14C from ADP[U-14C]glucose into methanol/KCl-insoluble products by starch granules from developing potato tuber. Incubations were for 1 h and contained 100 mM maltotriose (O) or no additions 10 (--).
Figure 10: Elution of debranched, 14C-labelled starch from a column of Sepharose CL-4B. Samples of isolated starch granules from pea embryos and starch granules which had been incubated with ADP[U-15 14C]glucose for 1 h were incubated with isoamylase prior to loading onto the column. Elution of unlabelled sample, as absorbance at 595 nm of fractions mixed with iodine (-); and elution of 14C-labelled, methanol/KCl-insoluble products from sample 20 incubated with ADP[U-14C]glucose (O).
Figure 11: Effect of pre-treatment with ~-glucosidase on the stimulatory influence of soluble extracts of potato tuber on amylose synthesis. Two, replicate 5-g samples of developing tuber were ~ 25 prepared. One was used for isolation of starch granules as described in Experimental procedures. The other was extracted in a mortar in a total of 10 ml of 50 mM sodium acetate (pH 5.5) with 0.5 g CA 0223~619 1998-04-22 polyvinylpolypyrrolidone. After centrifugation, the supernatant (soluble extract) was boiled for 5 min then samples were incubated for 18 h with or without 1.25 unit ml~l ~-glucosidase (yeast) at 35~C. After boiling again, all samples were brought to pH 7. The starch granules were resuspended at 25 mg ml~l in Medium A (~ glucosidase-treated soluble extract (O) or untreated soluble extract (~) and incubated for 1 h with ADP[U-l4C]glucose. The methanol/KCl-insoluble products were subjected to chromatography onSepharose CL-2B.
Figure 12: Comparison of the effects of maltotriose on incorporation of 14C from ADP[U-l4C]glucose by starch granules from wild-type and lam mutant pea embryos. Wild-type: ~, with 100 mM
maltotriose; ~, without maltotriose lam mutant-: O, with 100 mM maltotriose; ~, without maltotriose Figure 13: Effect of malto-oligosaccharides on incorporation of 14C from ADP[U-l4C]glucose into methanol/KCl-insoluble products by starch granules from developing potato tuber. Incubations contained 100 mM maltotriose (~) or no additions (-).
All documents mentioned herein are lncorporated by reference.
.RT~T..c AND METHODS
Plant material CA 0223~619 1998-04-22 Peas were of a round-seeded line ( Pisum sa tivum L., BC1/12 RR: see Smith 1990 for derivation of this line) or a low-amylose (lam) mutant line (SIM 503) derived from the round seeded line (Denyer at al.
1995a). Both were obtained from Dr. Cliff Hedley and Dr. Trevor Wang, John Innes Centre, Norwich. Plants were grown as described by Denyer et al. (1995a).
Potatoes (Solanum tuberosum L. cv Desiree) were grown as described by Edwards et al. (1995).
Preparation o~ starch Starch was prepared from developing pea embryos essentially according to Smith (1990). Approximately 1-3 g of embryos of fresh weight 200-400 mg was homogenised in a mortar with 5-15 ml 100 mM Tris-acetate (pH 7), 0.5 M NaCl, 1 mM dithiothreitol (DTT), 1 mM ethylenediaminetetraacetic acid (EDTA) at 4~C.
The homogenate was filtered through two layers of Miracloth (Behring Diagnostics, La Jolla, CA, USA), and the residue was washed in the filter cloth with a further 5-15 ml of extraction medium. The combined filtrate was stirred at 4~C for 30 min and then subjected to centrifugation at 2000 g for 10 min. The supernatant and the green material from the surface of the pellet were discarded and the pellet was resuspended in 10 ml extraction medium. This centrifugation and resuspension procedure was repeated, once with extraction medium and three times CA 0223~619 1998-04-22 W O 97/16~54 PCT/GB96/02696 with 50 mM Tris-acetate (pH 8), 1 mM DTT, 1 mM EDTA.
The pellet was resuspended in acetone cooled to -20~C
and allowed to settle for 15 min, and then the supernatant was discarded. This acetone wash was repeated twice more and the washed starch was dried under air at room temperature. The starch was either used immediately or stored at -20~C for up to 2 months.
Starch was prepared from developing potato tubers (each 10-100 g fresh weight) essentially as described above for pea embryos except that the extraction medium was-50 mM Tris-acetate (pH 8), 1 mM DTT, 1 mM
EDTA, stirring at 4~C was omitted and the total number of washes in extraction medium was 3-4.
Incubation of gr~n~-l t~S with ADPglucose Starch granules were resuspended at lmg per 40 ~l in 100 mM 3-(N-morpholino)propanesulphonic acid (Mops, pH 7.2), 5 mM MgCl2, 50 ml.l 1 glycerol, 2 mM DTT, 1 g 1-l bovine serum albumin. Each incubation contained 10 ~ul starch suspension and 90 ,ul 100 mM Bicine (pH
8.5), 25 mM potassium acetate, 10 mM DTT, 5 mM EDTA, 1 mM ADP[U-14C]glucose (Amersham International, Bucks, UK) at 18.5 GBq.mol~1 and was incubated at 25~C for 1 hour. The incubation was terminated either by heating for 2 min at 90~C followed by the addition of 3 ml 750 ml.l~1 aqueous methanol containing 10 g.l~1 KCl (methanol-KCl) or by the addition of methanol-KCl CA 0223~619 1998-04-22 alone. After incubation at room temperature for a minimum of 5 min, the precipitated starch was collected by centrifugation at 2000 g for 5 min. The supernatant was discarded and the pellet was resuspended in 0.3 ml distilled water. This methanol-KCl wash, centrifugation and resuspension was repeated twice more except that after the final centrifugation the distilled water was omitted and the pellet was dried in air at room temperature for a m; n;mllm of 10 min. The washed starch pellet was dissolved in 50 ,ul of 1 M NaOH, diluted with 50 ~l distilled water, and subjected to gel filtration chromatography.
Isoamylase digestion Starch granules were incubated with ADPglucose and washed with methanol-KCl as described above. The dried starch pellet was resuspended in 25 ul 50 mM
sodium acetate (pH 3.5) containing 4000 units isoamylase ~Sigma, Poole, Dorset, UK) and incubated at 37~C for 24 h. The starch was then dissolved in 50 ul 1 M NaOH, diluted with 25 ~l distilled water, and subjected to gel filtration chromatography.
Gel ~iltration chromatography on Sepharose CL-2B
Samples were either unlabelled starch which was dissolved in 1 M NaOH at 20 mg. ml~l and diluted with distilled water to 0.5 M NaOH or l4C-labelled starch prepared as described above. A 50-~l sample of CA 0223~619 1998-04-22 dissolved starch was applied to a column (0.5 cm i.d.
x 30 cm) of Sepharose CL-2B equilibrated with 100 mM
NaOH, and eluted with this solution (Denyer et al.
1995a). Fractions of 0.15-0.17 ml were collected at the rate of one fraction per minute. Glucans in fractions from unlabelled samples were detected by their reaction with iodine as described in Denyer et al. (1995a). Radioactivity in fractions from samples containing labelled glucans was determined by liquid scintillation counting on a Wallac 1410 counter (Wallac UK, Milton Keynes, UK) using 1 or 3 ml HiSafe II liquid scintillation fluid (Beckman Ltd., High Wycombe, Bucks, UK) per fraction.
SDS-polyacryl ;~ gels As described in Denyer et al. (1995).
As~ay o~ granule-bound starch synthase activity Assays contained 100 mM Bicine (pH 8.5), 25 mM
potassium acetate, 10 mM DTT, 5 mM EDTA, 1 mM ADP[U-14C]glucose (Amersham International, Bucks, UK) at 2.3 GBq mol-1 and 10 ul of a suspension of starch granules in a ~inal volume of 100 ul. Assays were incubated at 25~C for 15 min and then heated to 90~C for 2 min.
Controls were heated to 90~C immediately after the addition of starch granules to the assay. All assays and controls were duplicated. Starch was precipitated with methanol-KCl and washed as described above -CA 0223~6l9 l998-04-22 (Incubation of starch granules with ADPglucose) except that the final pellets were dissolved in 0.3 ml of distilled water followed by 3 ml HiSafe II liquid scintillation fluid. Radioactivity was determined by liquid scintillation counting.
RESULTS
Identification o~ the products o~ GBSS
The starch synthase activity of starch granules isolated from pea embryos was measured as the incorporation of 14C from ADP[U-14C]glucose into material which was insoluble in 750ml.1 l methanol containing lOg.l~1 KCl (methanol/KCl). This activity was specific for ADPglucose (there was almost no activity with UDPglucose - at lmM the activity was less than 3% of that with ADPglucose at the same concentration) and the incorporation was linear with respect to time for at least lh. The 14C-labelled methanol/KCl-insoluble material was completely solubilised after incubation with amyloglucosidase (not shown), showing that the products of the reaction were glucans (~-1,4, ~-1,6 linked). In control assays, which were terminated immediately after the addition of the substrate, incorporation of-14C into glucans was minimal (less than 3% of that in assays which were incubated for lh).
Sepharose CL-2B chromatography of pea starch results in a clear separation of the amylose and CA 0223~619 1998-04-22 amylopectin components (Fig. la). Amylopectin is the first peak of glucan to elute, and amylose the second (Denyer et al. 1995a). When the methanol/KCl-insoluble products from incubation of isolated starch granules with ADP[U-l4C]glucose were subjected to chromatography on a column of Sepharose CL-2B, 14C
eluted predom,n~ntly in the amylopectin peak (Fig.
lb). In seven experiments, the average recovery of 14C
in the amylopectin peak as a percentage of the total 14C eluted from the column was 78 + 12% (mean ~ SD).
The total 14C recovered in the fractions eluting from the column in these and subsequent experiments was 70-100~ of that applied to the column, hence there were no major losses of labelled products on the column.
To investigate whether the 14C co-eluting with amylopectin was in amylopectin or in high-molecular-weight amylose molecules, the products were treated with isoamylase to debranch glucans prior to application to the column. After isoamylase treatment the 14C eluted much later from the column (Fig. 2), indicating a lower molecular weight. In control treatments with buffer instead of isoamylase, the position of elution of 14C was unaltered (data not shown). These results are consistent with incorporation of 14C glucose via GBSS into the branches of amylopectin molecules rather than into linear polymers.
The starch granules used in these experiments CA 0223~619 1998-04-22 were prepared by washing insoluble extracts of developing pea embryos several times in aqueous media, then in cold acetone followed by drying in air and storage at -20~C for up to two months before being assayed. To determine whether these preparation or storage methods influenced the type of products made by the GBSSs, granules prepared by the following alternative methods were assayed: 1) freshly-prepàred granules which had not been stored at -20~C and 2) freshly-prepared granules which were washed with aqueous media but not washed with acetone or air~
dried. In both of the above experiments the elution profile of 14C was essentially the same as that shown in Fig lb: the incorporation was very largely into amylopectin.
Hylton et al. (1995) found that mechanically-damaged starch granules from barley endosperm had a higher GBSS activity than intact granules, and that most of the increase~in activity was due to isoforms other than GBSSI. In the light of this result we investigated whether in our experiments the pattern of incorporation of glucose was affected by damage to the granules. Granules were prepared with the minimum of mechanical damage by chopping the developing pea embryos with a razor blade into extraction medium rather than by grinding in a mortar. The activity (per mg starch) of granules prepared from chopped pea embryos was approximately half that of granules CA 0223~619 1998-04-22 W~D97/16554 PCT/GB96/02696 prepared by grinding. However, there was no change in the nature of the products which were synthesised (not shown). There was no change in the pattern of incorporation of 14C into polymers: most of the incorporation in the granules prepared by chopping rather than grinding was into amylopectin (not shown).
Analysis o~ the size o~ the l4C-l~ll~ amylopectin ~h A ; n .~
To investigate the average Length of amylopectin chains into which 14C was incorporated, the products of the incubation of pea starch granules with ADP[U-l4C]glucose were debranched with isoamylase and subjected to chromatography on a column of Sepharose CL-4B. The first peak of glucan to elute from the column in the experiment shown in Figure 10 consisted of amylopectin which had not been completely debranched. Glucan eluting later from the column consisted of chains of debranched amylopectin.
Comparison of the elution profiles of 14C-labelled and unlabelled amylopectin chains showed that the peak of the former eluted earlier than the latter. This suggests that the chains elongated via starch synthases during the incubation were considerably longer than the average chains in the amylopectin molecules.
Comparison of -~tarch ~rom wild-type and l~m mutant CA 0223~619 1998-04-22 embryos To investigate whether the observed elongation of amylopectin was due to the activity of GBSSI, GBSSII
or both of these isoforms, we compared the incorporation of 14C-glucose from ADP[U-l4C]glucose into starch from wild-type and lam mutant pea embryos.
Starch granules from lam mutant embryos lack GBSSI, therefore incorporation into these granules must be via GBSSII alone. The incorporation into granules from lam mutant embryos was entirely into the amylopectin fraction (Figure 3). This shows that GBSSII of pea embryos can elongate amylopectin branches within the granule.
As reported previously, the total incorporation of 14C glucose into granules of lam mutant embryos was lower than granules of wild-type embryos on a starch basis (Denyer et al. 1995a). To discover whether this reduction in incorporation was due solely to the absence of GBSSI, or whether the mutation also resulted in a reduction in the amount of GBSSII, granule-bound proteins from both starches were extracted and compared on SDS-polyacrylamide gels (Fig 4). The amount of GBSSII protein per mg of starch was the same in the wild-type and the mutant. Assuming - 25 that the activities of the GBSSs were not grossly affected by structural differences between the starches, this suggests that the difference between the starches of wild-type and lam embryos in their -CA 0223~619 1998-04-22 ability to incorporate glucose from ADPglucose into amylopectin is attributable to the activity of GBSSI.
The effect of the soluble fraction o~ storage organs on the products of the GBSSs The above experiments show that GBSSI in isolated starch granules transfers glucose from ADPglucose largely to amylopectin rather than to amylose molecules. Since this isoform is responsible for the synthesis of amylose in vivo, some factor(s) present in vivo but not in isolated starch granules may be required for amylose synthesis. To investigate whether soluble factors required for amylose synthesis had been washed out of the starch granules during their preparation, we compared the methanol/KCl-insoluble products of incorporation from ADP[U-14C]glucose by crude homogenates of developing pea embryos (containing both soluble and insoluble fractions) and washed starch granules derived from the homogenates (Figure 5). Crude homogenates gave a higher total incorporation of l4C-glucose than washed starch granules, due to an appreciably greater incorporation into amylose. When the soluble ~raction derived by centrifugation of crude extracts was added back to the washed starch granules, a stimulation of incorporation into amylose was observed equivalent to the amylose synthesis in crude homogenates. Boiling the soluble extract prior to this addition did not CA 0223~619 1998-04-22 effect its ability to stimulate amylose synthesis, shwoing that the stimulatory factor was heat-stable and suggesting that soluble enzymes were not required (not shown).
- 5 We investigated whether developing potato tubers also contained soluble factors which could stimulate the activity of GBSS. GBSS activity in crude homogenates of tuber is considerably greater than that in washed starch granules derived from the same homogenate. As with pea embryos, the addition of boiled, soluble extract to the washed starch granules stimulates the GBSS activity (Table 1) and promotes the synthesis of amylose (Figure 11).
Taken as a whole, these experiments suggest that soluble extracts of pea embryos and potato tubers contain non-enzymic factors which stimulated amylose synthesis in the granule. Leloir et al. (1961) found that GBSS activity was stimulated by the presence of maltose, maltotriose or maltotetraose and presented evidence to suggest that these malto-oligosaccharides could act as substrates for GBSSs in granules isolated from Phaseolus vulgaris. Although the work of Leloir et al. involved the transfer of glucose from UDPglucose, an activity which is not present to any - 25 significant extent in our preparations of starch granules, it seemed possible that the stimulatory factors in our soluble extracts are malto-oligosaccharides which act as primers for amylose CA 0223~619 1998-04-22 W ~ 97/16554 PCT/GB96/02696 synthesis. To investigate this, boiled, soluble extracts of potato tuber were treated with ~-glucosidase (maltase) to remove malto-oligosaccharides. This treatment eliminated the ability of the extracts to stimulate GBSS activity of isolated starch granules, and to promote incorporation of 14C into amylose (Table 2, Figure 6).
In three separate experiments, the granule-bound starch synthase activity relative to that of starch granules resuspended in Medium A was 154.-3% + 16.5%
(mean ~ SD) for starch granules resuspended in untreated soluble extract and 109.8~ + 8.9% (mean +
SD) for starch granules resuspended in ~-glucosidase-treated soluble extract. The results from the analysis of one of these experiments is shown in Figure 11. Taken as a whole, these experiments suggest that soluble extracts of pea embryos and potato tubers contain malto-oligosaccharides which can stimulate amylose synthesis in starch granules.
We therefore investigated whether purified malto-oligosaccharides could promote amylose synthesis by isolated granules. The results are presented below.
The effects o~ malto-oligo-~h~ides on GBSS activity ~hen supplied to isolated starch granules from pea embryos, a range of small malto-oligosaccharides, from maltose to maltohexaose, stimulated the incorporation o~ 14C-glucose from ADP[U-l4C]glucose CA 0223~619 1998-04-22 into material eluting from Sepharose CL-2B in the same position as, or slightly after amylose. Incorporation into amylopectin was reduced (Figure 7), and incorporation into material eluting from a Sepharose CL-2B column in the same position as, or slightly after, amylose was greatly stimulated. Maltoheptaose and a mixture of malto-oligosaccharides with from four to ten glucose units had a similar effect (data not shown). With maltose, the effect was apparent at concentrations of lOmM, and was fully saturated at lOOmM. Neither lOOmM glucose nor lOOmM cellobiose had any effect on incorporation, showing that the stimulatory effect was specific for malto-oligosaccharides (data not shown).
To determine whether the synthesis of amylose in the presence of malto-oligosaccharides was due to the activity of GBSSI, GBSSII or both, the products formed in the presence of maltotriose by granules from wildtype and lam mutant embryos were compared (Figure 8 and Figure 12). Maltotriose had no effect on the products synthesised by starch granules from lam mutant embryos, showing that GBSSII alone could not synthesise amylose in the presence of malto-oligosaccharides. The amylose synthesis observed in wild-type granules in the presence of malto-oligosaccharides is therefore likely to be due to the activity of GBSSI.
CA 0223~619 1998-04-22 W ~ 97/16554 PCT/GB9~/02696 The e~fect of malto-oligo-Q~r~h~ides on the GBSS
activity o~ starch from potato tubers We compared the effects of malto-oligosaccharides on pea starch with the effects on starch isolated from developing potato tubers. The Sepharose CL-2B column was less effective in separating amylose and amylopectin from potato starch than from pea starch (not shown) but it was nonetheless clear that in the abse~ce of maltotriose, incorporation of 14C from ADP[U-14C]glucose was largely into the amylopectin peak. See Figure 13. In the presence of maltotriose, the incorporation into amylopectin was reduced dramatically and there was an increase in incorporation into amylose (Figure 9). These results are similar to those obtained with pea starch and were consistent with the idea that GBSSI of potato starch elongates amylopectin in the absence o~ maltotriose and synthesises amylose in the presence of maltotriose.
DISCUSSION
Our results show that both GBSSI and GBSSII of developing pea embryos elongate glucans within starch granules. GBSSI can elongate the branches o~
amylopectin as well as elongating maltose and higher oligomers o~ glucose. GBSSII can elongate amylopectin but apparently cannot elongate short malto-oligosaccharides. Thus only GBSSI can initiate the , CA 0223~6l9 l998-04-22 synthesis of amylose. We cannot rule out from our present studies the possibility that GBSSII could contribute to the elongation of amylose, once these molecules have reached a certain size.
The properties of the GBSSI of developing pea embryo described in this paper should represent the properties of this class of starch synthases generally. Baba et al. (1987) showed that granules isolated from sweet potato tubers incorporated 14C from ADP[U-14C]glucose primarily into amylopectin. Malto-oligosaccharides were not supplied in these experiments. Leloir et al. (1961) showed that malto-oligosaccharides could act as primers for starch synthesis in granules from developing beans. We have shown that malto-oligosaccharides are required to stimulate amylose synthesis in isolated granules from potato tubers as well as pea embryos.
Starches from many starch storing organs possess GBSSs very similar in size, antigenic properties and/or sequence to GBSSII of pea. The properties of all members of the GBSSII class are likely to be similar, so elongation of amylopectin via these isoforms within the granules of starches other than pea may also occur. However, there is variation between starches from different sources in the types and numbers of GBSSs other than GBSSI (Smith et al.
1995). At present, we have no information on the ability of GBSSs other than GBSSI and GBSSII to CA 0223~619 1998-04-22 ~TO 97/16554 PCT/G B96/02696 elongate amylopectin within the granule. Starches from different sources also vary in the extent to which GBSSs other than GBSSI contribute to the total GBSS activity. For example the activity of GBSSII is very low compared to the activity of GBSSI in potato tubers (Edwards et al. 1995). This may account for the much lower incorporation into amylopectin in the presence of maltotriose in potato starch than in pea starch (Figs 8 and 9). Thus the contribution of GBSSs to amylopectin synthesis within the granule may differ between starches because both the total activity and the properties of these enzymes may vary.
In isolated granules, the overall activity of GBSSI and the nature of its products depends upon the availability of malto-oligosaccharides. We have demonstrated the presence in crude extracts of pea and potato of compounds which are susceptible to degradation by ~-glucosidase, and which stimulate amylose synthesis in isolated granules. These malto-oligosaccharides may be produced in vivo by the actionof starch-degrading enzymes. It has long been known that such degradative enzymes are present during starch synthesis and some of these have been shown to be plastidial. Our results suggest that one role of the degradative enzymes may be to produce primers for amylose synthesis.
CA 0223~619 1998-04-22 GBSS activity (,umol.min~l.g~l FWT) Homogenate 0.171, 0.198 Washed pellet 0.063, 0.093 Washed pellet + boiled ~u~ al~lll 0.149, 0.147 GBS5 activi ty in fractions of crude extracts of devel oping po ta to tubers .
Samples o~ developing tubers were homogenised, and washed pellet (containing starch granules) and supernatant (containing soluble material) ~ractions 15 were prepared as described in Figure 5 for pea embryos Starch synthase activity was assayed in the homogenate and the supernatant, and the latter value subtracted ~rom the ~ormer to give GBSS activity in the homogenate. Hal~ of the washed pellet was 20 resuspended in 1.5 ml extraction medium and hal~ in 1.5ml boiled supernatant, and both samples were assayed ~or starch synthase activity. Boiled supernatant contained no detectable starch synthase activity. In these experiments, amylopectin (potato;
25 Sigma, Poole, Dorset, UK) was included in the assays at 5 mg ml~1. Values are ~or samples ~rom two, separately-extracted tubers.
.
SUBSTilUTE SHLET (RULL 26) CA 0223~619 1998-04-22 W'~97/16554 PCT/GB96/02696 ~ 54 GBSS activity (nmol.min~l.mg~l starch) buffer 0.708 u~ L~d supernatant 1.170 treated supernatant 0.751 Ef~ect of ~-glucosidase treatment on stimulation of GBSS activity by crude extracts of developing potato tubers.
Two, replicate samples, each of 5 g, of developing tuber were prepared. One was used ~or isolation of acetone-washed starch granules as described in Materials and Methods. The other was extracted in a mortar in a total of 10 ml of 50 mM Na acetate (pH 5. 5) with 0. 5 g polyvinylpolypyrrolidone.
After centrifugation, the supernatant was boiled for 5 min then samples were incubated overnight with or without 1. 25 unit.ml~ -glucosidase (yeast) at 35~C
A~ter boiling again, all supernatant samples were brought to pH 7 and used to resuspend starch granules (prepared from the other sample of tuber) for assay.
Buf~er = starch resuspended in Mops medium as described in Materials and Methods, untreated ~upernatant = supernatant incubated without ~-glucosidase, treated supernatant = supernatantincubated with ~-glucosidase.
SUBSTITUTE SHEET (RULE 26) CA 0223~619 1998-04-22 Ainsworth et al. (1993) Plant Mol. Biol. 22, 67-87.
Baba et al, (1987). Starke 39, 52-56 Bernfeld P (1951) Enzymes of starch degradation and synthesis. In: Advances in Enzymology Vol. 12. New York, Interscience Publishers. pp 379-428 Bevan M (1984) Nucl. Acids Res. 12, 8711-8721 Cornish-Bowden A (1995) Fundamentals of enzyme kinetics. London, Portland Press Denyer et al, (1995a). L. Plant Cell Env. 18, 1019-Denyer et al, (1995b). Planta 196, 256-265 Denyer et al, (1993). Plant J. 4, 191-198 Edwards et al, (1995). Plant J. 8, 283-294 Federoff et al, (1982). J. Bact. 149, 1064-1070 Frohman et al. GR (1988) Proc. Natl Acad. Sci. USA 85, Frydman et al, (1967). J. Biol. Chem. 242, 312-317 Guerineau F, Mullineaux P (1993) Plant transformation and expression vectors. In: Plant Molecular Biology Labfax (Croy RRD ed) Oxford, BIOS Scientific Publishers, pp 121-148 Hong SH, Marmur J (1986). Gene 41, 75-84 Hylton et al, (1995). Planta, in press James et al. (1995) Plant Cell 7, 417-429 Jenner et al. (1994) Aust. J. Plant Physiol. 21, 17-22 Kawazu et al, (1987). J. Bact. 169, 1564-1570 Kelly CT, Fogarty WM (1983). Process Biochem. May-CA 0223~619 1998-04-22 June, pp 6-12 Klosgen RB, Weil J-H (1991) Mol. Gen. Genet. 225, 297-van der Leij et al, (1991). Theor. Appl. Genet 82, Kreis et al, (1987). Eur. J. Biochem. 169, 517-525 Leloir et al, (1961). J. Biol. Chem. 236, 636-641 Lin et al, (1991). Plant Physiol. 95, 1250-1253 Lowry OH, Passonneau JV (1971) A flexible system of enzymatic analysis. New York, Academic Press Macdonald FD, Preiss J (1983). Plant Physiol. 73, 173-Marshall et al. (1996) Plant Cell 8, 1121-1135 Martin C, Smith AM (1995). Plant Cell 7, 971-985 Monroe et al, (1991). Plant Physiol. 97, 1599-1601 Nakano et al, (1989). J. Biochem. 106, 691-695 Needleman et al. (1978) Biochem. J. 17, 4657-4661 Shewmaker et al, (1994). Plant Physiol. 104, 1159-1166 Siggens KW (1987). Mol. Microbiol. 1, 86-91 Smith AM (1990). Planta 182~ 599-604 Smith AM, Martin C (1993) Starch biosynthesis and the potential for its manipulation. In: Biosynthesis and manipulation of plant products (Grierson D ed.) pp 1-54. Blackie Academic and ProfessionaL, Glasgow Smith et al, (1995). Plant Physiol. 107, 673-677 Spychalla JP, Bevan MW (1993) Agrobacterium-mediated transformation of potato stem and tuber tissue, regeneration and PCR screening for transformation. In:
CA 0223~619 1998-04-22 Plant Tissue Culture Manual B11 (Gelvin SB, Schilperoot RA eds) Dordrecht: Kluwer Academic Publishers, ppl-18 Sonnewald et al, (1995). Plant Mol. Biol. 27, 567-576 Steup M (1988) Starch degradation. In: Biochemistry of Plants,Vol. 14 (Preiss J ed.) pp 255-296. Academic Press, San Diego Steup M (1990) Enzymes of starch degradation. In:
Methods in Plant Biochemistry, Vol. 3 (Lea PJ ed.) pp 103-128. Academic Press, San Diego Takaha et al, (1993). J. Biol. Chem. 268, 1391-1396 Watanabe et al, (1990). Eur. J. Biochem. 192, 609-620 Yoshida et al, (1992). Gene 120, 255-259
The results indicate that the presence of MOS in the amyloplast in vivo is a prerequisite for the synthesis of amylose via GBSSI and that GBSSI activity is redirected from amylose to amylopectin in the absence of MOS. Accordingly, the present inventors have realised that manipulation of MOS levels in planta provides a means for manipulation of starch produced by the plant, in particular the nature of the amylopectin component of the starch.
The implications and applications of this work CA 0223~619 1998-04-22 are many-fold. Manipulation of the level of MOS in amyloplasts of the storage organ of a plant will affect amylose synthesis by GBSSI and action of GBSSI
on chains of amylopectin. Accordingly, the properties of the starch produced by the plant will be modified.
There is considerable interest in modifying starch and creating and investigating novel properties. Starch is of major interest in many industries, including the food, paper, oil, glue, tobacco and textile industries. For instance, starch, modified or otherwise, is used in beer, animal feeds, baking products such as biscuits, doughnuts, pies, crisps, in canned foods such as soups, fruits and vegetables, in cereals, in condiments such as ketchup, in fats and oils such as margarine, in dried foods, syrups and sweeteners, in a whole host of other foods, in building materials such as cardboard, ceramics, fiberboard and fiberglass, paints, in numerous chemical products and processes, in crayons-and chalk, cord, string, in metallurgy, explosives, rubber, textiles, dyes and in tobacco. Potato starch, for example, is used for sizing and surface coating in the paper industry, in sizing of cotton, worsted and spun rayon wraps, and in finishing sewing thread and cloth in the textile industry.
"Waxy corn", in which the starch is composed entirely of amylopectin (a branched ~-glucan) as compared with 72 percent amylopectin and 28 percent CA 0223~619 1998-04-22 amylose (an unbranched ~-glucan) in common corn starch. Several alleles have been observed at the waxy locus. See, for example, "CORN - Improvement, Seed Production and Uses", Jugenheimer (1976), John Wiley & Sons, USA, for a discussion.
A group including Visser at the Agricultural University and CPRO Institute in Wageningen, The Netherlands, have used anti-sense technology targeting waxy protein expression to produce a waxy starch potato. This work was commissioned by the paper industry, providing further illustration of the interest in starch modification and its importance.
According to a first aspect of the present invention there is provided a method comprising modulating the amount of malto-oligosaccharide (MOS) present in a plant cell. Specifically amyloplasts of a storage organ of a plant are of interest. Altering the level of malto-oligosaccharide in the cell affects GBSSI production of amylose and amylopectin thereby influencing the nature of the starch produced.
In one embodiment of the present invention, malto-oligosaccharide in the cell is depleted. Any mechanism that reduces or eliminates MOS from amyloplasts of a developing storage organ prevents or ~ 25 reduces amylose synthesis by GBSSI. GBSSI action upon the chains of amylopectin in the granule is concomitantly increased. This results in a starch which lacks or has reduced levels of amylose, and has CA 0223~619 1998-04-22 an amylopectin structure that is different from that of both wild-type starches and the starch of mutant and transgenic plants which lack or have very low levels of GBSSI (for example the waxy mutants of maize, barley, sorghum rice and Amaranthus, the amf mutant of potato, the lam mutant of pea, and transgenic potatoes expressing an antisense construct containing any GBSSI sequence: specific literature references in Smith and Martin 1993) and may be different from that of wild-type starch. The amylopectin of plants which lack or have very low levels of MOS should have longer branches than amylopectin from wild-type plants or plants with altered levels of GBSSI of the same species, and may have longer branches than the amylopectin from wild-type plants of the same species.
Thus an aspect of the present invention provides a method of modifying amylopectin produced in a plant cell (or a method of producing modified amylopectin in a plant cell), the method comprising modulating the amount of malto-oligosaccharide (MOS) in the cell.
Altering the MOS level within the cell affects the action of GBSSI, and thus alters the amylose and amylopectin contents of the cell. In preferred embodiments, MOS is depleted (wholly (which includes substantially wholly) or partially) within the cell, leading to modified amylopectin production. The use of a substance which reduces the level of malto-CA 0223~619 1998-04-22 W O 97tl6554 PCT/GB96/02696 oligosaccharide in a plant cell in modifying starch produced in the cell (especially the amylopectin component of the starch) is provided as a further aspect of the present invention.
~ 5 The level of MOS in a plant cell may be assessed quantitatively by the following method. First, the metabolism of the cell is stopped by extremely rapidly. Typically, the tissue is clamped in tongs cooled to the temperature of liquid nitrogen, then 10 allowed to thaw in 1 M perchloric acid. A soluble extract of the tissue at neutral pH suitable for enzymic assay of metabolites is then prepared. In the example above, the perchloric acid extract of the tissue is brought to neutrality with a suitable 15 alkaline solution such as 5 M potassium carbonate, and the resulting insoluble potassium perchlorate is removed by centrifugation. The extract is incubated with enzymes and other factors required to remove sucrose and glucose. This may be achieved, for 20 example, by the addition of invertase, glucose 6-phosphate dehydrogenasei adenosine triphosphate, nicotinamide adenine dinucleotide, and magnesium chloride at appropriate concentrations as described by Lowry and Passonneau (1971). The extract is then A 25 incubated with an excess of ~-glucosidase and ~-amyloglucosidase to hydrolyse MOS to glucose, and the glucose is assayed for example as described by Lowry and Passonneau (1971). The amount and nature of the CA 0223~619 1998-04-22 MOS in a tissue may be investigated by several methods utilising a fraction containing soluble neutral compounds obtained from an extact (prepared as described above) by ion-exchange chromatography.
These methods include thin-layer chromatography, paper chromatography, and high-performance anion-exchange chromatography with pulsed amperometric detection.
Partial or total elimination of MOS in an amyloplast may be achieved using an enzyme that uses MOS as a substrate, converting it into something else.
For example, suitable enzymes convert MOS to glucose.
One way of providing such an enzyme, or other substance that reduces MOS availability to GBSSI, to a plant cell is by expression within the cell of an encoding nucleic acid sequence. A preferred enzyme for this purpose is an ~-glucosidase (EC 3.2.1.20), which may have a strong maltase activity (ie a low Km for maltose) and possibly little or no isomaltase activity (ie little or no action on ~-1,6 linkages) or activity with starch granules. Obviously, it is preferred that the enzyme has a pH optimum within the range of pH likely to occur within the cytoplasm of the cell (typically 6.5-7.8).
Enzymes with such activity may be identified by their ability to hydrolyse the specific substrate 4-nitropenyl glucoside, as described by Needleman et al.
(1978). Incubation of the enzyme at an appropriate pH
and with a suitable concentration of the substrate CA 0223~619 1998-04-22 results in the appearance of a yellow colour as hydrolysis proceeds.
The Km for maltose or any other MOS may be defined by the incubation of the enzyme at a suitable pH with a range of concentrations of maltose or other MOS for a defined period over which the reaction has been established to proceed linearly. Measurement of the amount of glucose produced over the defined period by any suitably specific and sensitive means (for example by enzymic assay as described by Lowry and Passonneau, 1971) then provides a quantitative estimate of enzyme activity from which the affinity of the enzyme for its substrate may be calculated by any of the methods described for this purpose by Cornish-Bowden (1995).
The pH optimum of the enzyme may be discovered byincubation of the enzyme with a suitable substrate at a range of different pH (typically a range from 5.5 to 8.5) followed by measurement of the amount of substrate hydrolysed at each pH. The action of the enzyme upon starch may be examined by the measurement of the production of reducing sugars upon incubation of the enzyme with starch granules, or with solubilised polymers derived therefrom. A suitable method for the measurement of reducing sugars is described by Bernfeld (1951).
All of the above methods may be applied to purified or partially purified enzymes obtained from a -CA 0223~619 1998-04-22 WO 97/16~54 PCT/GB96/02696 commercial source or by purification or partial purification from any appropriate organism. Methods of purification are exemplified by that described for yeast by Needleman et al. (1978). The techniques described above may also be used to study enzymes in cell extracts prepared from any suitable organism.
However, any person skilled in the art will appreciate that cell extracts may contain several activities capable of the hydrolysis of MOS and/or starch, and definition of the properties of any one of these activities may not be possible without partial purification.
The maltase of the bacterium Bacillus amylolyticus and the maltase encoded at the M~l6 locus of the yeast Saccharomyces carlsbergensis are suitable (Kelly and Fogarty 1983): the gene for the Saccharomyces maltase has been cloned (Hong and Marmur 1986).
As necessary, any person skilled in the art may clone the gene for any desired maltase from a bacterium by, for example, an obvious modification of the E. coli transformation method used to clone an oligo-1,6-glucosidase from Bacillus cereus (Watanabe et al. 1990) or by complementation of a Saccharomyces strain carrying mutations in structural genes for maltase and thus unable to utilise maltose as a carbon source (Federoff et al. 1982). The efficacy of ~-glucosidase in destroying plant MOS that promote CA 0223~619 1998-04-22 W O 97/16~54 PCT/GB96/02696 amylose synthesis, thus allowing amylopectin synthesis rather than amylose synthesis by GBSSI, is demonstrated by experiments described in detail herein.
Genes may be cloned using in~ormation from sequences available in databases known to those skilled in the art. A method o~ obtaining nucleic acid may comprise hybridisation of an oligonucleotide or a nucleic acid molecule comprising such an oligonucleotide to target/candidate nucleic acid.
Target or candidate nucleic acid may, ~or example, comprise a genomic or cDNA library obtainable ~rom an organism known to contain or suspected of containing such nucleic acid. Success~ul hybridisation may be identified and target/candidate nucleic acid isolated for further investigation and/or use.
Hybridisation may involve probing nucleic acid and identifying positive hybridisation under suitably stringent conditions (in accordance with known techniques) and/or use o~ oligonucleotides as primers in a method o~ nucleic acid ampli~ication, such as PCR. For probing, pre~erred conditions are those which are stringent enough for there to be a simple pattern with a small number o~ hybridisations ldenti~ied as positive which can be investigated ~urther. It is well known in the art to increase stringency o~ hybridisation gradually until only a ~ew positive clones remain.
CA 0223~619 1998-04-22 U'O 97/16554 PCT/GB96/02696 1~
As an alternative to probing, though still employing nucleic acid hybridisation, oligonucleotides designed to amplify D~A sequences may be used in PCR
reactions or other methods involving amplification of nucleic acid, using routine procedures. See for instance "PCR protocolsi A Guide to Methods and Applications", Eds. Innis et al, 1990, Academic Press, New York.
On the basis of amino acid sequence information oligonucleotide probes or primers may be designed, taking into account the degeneracy of the genetic code, and, where appropriate, codon usage of the organism from the candidate nucleic acid is derived.
An oligonucleotide for use in nucleic acid amplification or probing may have about 10 or fewer codons (e.g. 6, 7 or 8), i.e is about 30 or fewer nucleotides in length (e.g. 18, 21 or 24).
Assessment of whether or not such a PCR product corresponds to the gene of interest may be conducted in various ways. A PCR band ~rom such a reaction might contain a complex mix of products. Individual products may be cloned and each one individually screened. It may be analysed by transformation to assess function on introduction into a plant of interest.
Nucleotide sequences employed in the present invention may encode a wild-type sequence (e.g. gene) selected from those available, or a mutant, CA 0223~6l9 l998-04-22 derivative, variant or allele, by way of insertion, addition, deletion or substitution of one or more nucleotides, of such a sequence. An alteration to or difference in a nucleotide sequence may or may not be reflected in a change in encoded amino acid sequence, depending on the degeneracy of the genetic code. In any case, mutants, derivatives and alleles useful in the present invention are those which retain a functional characteristic of the polypeptide encoded by the wild-type gene, i.e. maltase activity as discussed. Of course, changes to the nucleic acid which make no difference to the encoded amino acid sequence~are included.
The nucleic acid may be in the form of a recombinant vector, for example a plasmid or agrobacterium binary vector (Van den Elzen et al., 1985). The nucleic acid may be under the control of an appropriate promoter and regulatory elements for expression in a plant cell. In the case of genomic DNA, this may contain its own promoter and regulatory elements and in the case of cDNA this may be under the control of an appropriate promoter and regulatory elements for expression in the host cell.
Those skilled in the art are well able to construct vectors and design protocols for recombinant gene expression. Suitable vectors can be chosen or constructed, containing appropriate regulatory sequences, including promoter sequences, terminator CA 0223~619 1998-04-22 ~tO 97/16554 PCT/GB96/02696 fragments, polyadenylation sequences, enhancer sequences, marker genes and other se~uences as appropriate. For further details see, for example, Molecular Cloning: a Laboratory Manual: 2nd edition, Sambrook et al, 1989, Cold Spring Harbor Laboratory Press. Many known techniques and protocols for manipulation of nucleic acid, for example in preparation of nucleic acid constructs, mutagenesis, sequencing, introduction of DNA into cells and gene expression, and analysis of proteins, are described in detail in Short Protocols in Molecular Biology, Second Edition, Ausubel et al. eds., John Wiley & Sons, 1992.
The disclosures of Sambrook et al. and Ausubel et al.
are incorporated herein by reference. Specific procedures and vectors previously used with wide success upon plants are described by Beran (1984) and Guerineau and Mullineaux (1993).
Selectable genetic markers may be used consisting of chimaeric genes that confer selectable phenotypes such as resistance to antibiotics such as kanamycin, hygromycin, phosphinotricin, chlorsulfuron, methotrexate, gentamycin, spectinomycin, imidazolinones and glyphosate (Herrera-Estrella et al, 1983; van den Elzen et al, 1985).
Introduction or elevation of activity of ~-glucosidase into amyloplasts of the developing storage organs of crop plants may be achieved using any appropriate method of plant transformation to generate CA 0223~619 1998-04-22 plant cells comprising nucleic acid with a sequence encoding the enzyme. Plants may be regenerated from transformed plant cells and tissue.
For example, potato may be transformed by incubation of tuber slices with Agrobacterium cells carrying the gene of interest and a gene encoding resistance to kanamycin in a suitable construct (Spychalla and Bevan, 1993). After co-cultivation for two days on tobacco feeder layers, discs are transferred onto Murashige and Skoog (MS) medium containing cefotaxime to select against Agrobacterium, then transferred to agar plates containing MS medium, cefotaxime, and kanamycin to select for growth of transformed cells. Shoots are excised from the discs and subcultured twice on MS medium containing kanamycin before transfer to soil.
When introducing a chosen gene construct into a cell, certain considerations must be taken into account, well known to those skilled in the art. The nucleic acid to be inserted should be assembled within a construct which contains effective regulatory elements which will drive transcription. There must be available a method of transporting the construct into the cell. Once the construct is within the cell membrane, integration into the endogenous chromosomal material either will or will not occur. Finally, as far as plants are concerned the target cell type must be such that cells can be regenerated into whole CA 0223~619 1998-04-22 plants.
Plants transformed with the DNA segment containing the sequence may be produced by standard tec~niques which are already known for the genetic manipulation of plants. DNA can be transformed into plant cells using any suitable technology, such as a disarmed Ti-plasmid vector carried by Agrobacterium exploiting its natural gene transfer ability (EP-A-270355, EP-A-0116718, NAR 12(22) 8711 - 87215 1984), particle or microprojectile bombardment (US 5100792, EP-A-444882, EP-A-434616) microinjection (WO 92/09696, WO 94/00583, EP 331083, EP 175966, Green et al. (1987) Plant Tissue and Cell Cul ture, Academic Press), electroporation (EP 290395, WO 8706614 Gelvin Debeyser - see attached) other forms of direct DNA uptake (DE
4005152, WO 9012096, US 4684611), liposome mediated DNA uptake (e.g. Freeman et al. Plant Cell Physiol.
29: 1353 (1984)), or the vortexing method (e.g.
Kindle, PNAS U.S.A. 87: 1228 (199Od) Physical methods for the transformation of plant cells are reviewed in Oard, 1991, Biotech. Adv. 9: 1-11.
Agrobacterium transformation is widely used by those skilled in the art to transform dicotyledonous species. Recently, there has been substantial progress towards the routine production of stable, fertile transgenic plants in almost all economically relevant monocot plants (Toriyama, et al. (1988) Bio/Technology 6, 1072-1074; Zhang, et al. (1988) CA 0223~619 1998-04-22 Plant Cell Rep. 7, 379-384; Zhang, et al. (1988) Theor Appl Genet 76, 835-840; Shimamoto, et al. (1989) Nature 338, 274-276; Datta, et al. (1990) Bio/Technology 8, 736-740; Christou, et al. (1991) Blo/Technology 9, 957-962; Peng, et al. (1991) International Rice Research Institute, Manila, Philippines 563-574; Cao, et al. (1992) Plant Cell Rep. 11, 585-591; Li, et al. (1993) Plant Cell Rep.
12, 250-255; Rathore, et al. (1993) Plant Molecular 10 Biology 21, 871-884; Fromm, et al. (1990) Bio/Technology 8, 833-839; Gordon-Kamm, et al. (1990) Plant Cell 2, 603-618; D'Halluin, et al. (1992). Plant Cell 4, 1495-1505; Walters, et al. (1992) Plant Molecular Biology 18, 189-200; Koziel, et al. (1993) 15 Biotechnology 11, 194-200; Vasil, I. K. (1994) Plant Molecular Biology 25, 925-937; Weeks, et al. (1993) Plant Physiology 102, 1077-1084, Somers, et al. (1992) Bio/Technology 10, 1589-1594; WO92/14828). In particular, Agrobacterium mediated transformation is now emerging also as an highly efficient alternative transformation method in monocots (Hiei et al. ~l994?
The Plant Journal 6, 271-282).
The generation o~ fertile transgenic plants has been achieved in the cereals rice, maize, wheat, oat, and barley (reviewed in Shimamoto, K. (1994) Current Opinion in Biotechnology 5, 158-162.; Vasil, et al (1992) Bio/Technology 10, 667-674; Vain et al., 1995, Biotechnology Advances 13 (4): 653-671; Vasil, 1996, CA 0223~619 1998-04-22 Nature Biotechnology 14 page 702).
Microprojectile bombardment, electroporation and direct DNA uptake are preferred where Agrobacterium is inefficient or ineffective. Alternatively, a combination of different techniques may be employed to enhance the e~ficiency of the trans~ormation process, eg bombardment with Agrobacterium coated microparticles (EP-A-486234) or microprojectile bombardment to induce wounding followed by co-cultivation with Agrobacterium (EP-A-486233).
Following transformation, a plant may be regenerated, e.g. from single cells, callus tissue or leaf discs, as is standard in the art. Almost any plant can be entirely regenerated from cells, tissues and organs of the plant. Available techniques are reviewd in Vasil et al., Cell Culture and Somatic Cel Genetics of Plants, Vol I, II and III, Laboratory Procedures and Their Applications, Academic Press, 1984, and Weissbach and Weissbach, Methods for Plant Molecular Biology, Academic Press, 1989.
The particular choice of a transformation technology will be determined by its efficiency to transform certain plant species as well as the experience and preference of the person practising the invention with a particular methodology of choice. It will be apparent to the skilled person that the particular choice of a trans~ormation system to introduce nucleic acid into plant cells is not CA 0223~619 1998-04-22 essential to or a limitation of the invention, nor is the choice of technique for plant regeneration.
A suitable method for transforming potatoes such that the product of the introduced gene may be targeted to amyloplasts is exemplified by the work of Shewmaker et al. (1994). A plasmid pCGN1132S contains a 35S promoter, a transit peptide and 16 amino acids of the mature protein of the pea ribulose bisphosphate carboxylase small subunit gene. The gene encoding the enzyme of interest is cloned into the plasmid as an in-frame fusion with the 16 amino acids of the small subunit. The fusion gene is excised and cloned into the patatin promoter cassette pCGN2162. A DNA segment containing the 700-base pair patatin promoter, the transit peptide, the 16 amino acids of the small subunit, the gene of interest and a 300-base pair nos 3' region is excised and cloned into the binary vector pCGN1557. This plasmid is then transferred to Agrobacterium tumefaciens strain LBA4404 and used to 2 0 transform potatoes. The efficacy of this method for achieving targeting of proteins to amyloplasts is illustrated by immunoblots which show correct processing of the expressed protein in potato tubers.
The ability of the method to bring about alterations - 25 of starch structure in potatoes is illustrated by its use to introduce a gene encoding a bacterial glycogen synthase (Shewmaker et al., 1994) The amylopectin of transformed plants had fewer longer branches and more shorter branches than control plants.
A second method which may be used to target an ~-glucosidase to the amyloplasts of the storage organs of crop plants is exemplified by the work of Klosgen and Weil (1991). In a procedure similar to that described above, these workers fused DNA encoding the transit peptide and 34 amino acids of the mature waxy protein of maize to the gene encoding the ~-glucuronidase of ~. col i . Introduction of the construct into potato plants via an Agrobacterium based method led to expression of the fusion protein in chloroplasts and amyloplasts of the transgenic plants.
Levels of MOS in a cells may be reduced via a reduction within that cell in the activity of one or more of the endogenous enzymes capable of generating MOS. Such enzymes, and methods for their identification and the cloning of genes that encode them, are discussed elsewhere herein. Reductions in activity may be achieved by the introduction into the cell of a gene - or part thereof - in the antisense orientation, such that an antisense RNA is produced within the cell. The gene or part thereof will encode the endogenous enzyme or another enzyme sufficiently similar in sequence to the gene encoding the endogenous enzyme. The introduction of the gene may be achieved by any suitable transformation method, as discussed elsewhere herein. Development and use of CA 0223~619 1998-04-22 constructs containing genes in the antisense orientation to bring about a reduction in an enzyme activity is exemplified by the work of Edwards et al.
(1995)and Marshall et al. (1996), who employed this technology to bring about large reductions in specific forms of starch synthase within the potato plant.
A further aspect of the invention provides a starch-producing cell of a plant, the level of malto-oligosaccharide in the cell being reduced comparedwith the level in an equivalent wild-type cell and the starch having an increased or modified amylopectin component compared with the starch produced by the equivalent wild-type cell. Preferably, the level of malto-oligosaccharide is reduced by virtue of expression within the cell of a polypeptide with maltase activity (as disclosed) from heterologous encoding nucleic acid therefor.
The term "heterologous" indicates that the gene/sequence of nucleotides in question has been introduced into cells of the plant or an ancestor thereof, using genetic engineering, i.e. by human intervention. The gene may be on an extra-genomic vector or incorporated, preferably stably, into the 2 5 genome.
The cell may comprise the nucleic acid encoding the enzyme by virtue of introduction into the cell or an ancestor thereo~ of the nucleic acid, e.g. by _ CA 0223~619 1998-04-22 W ~ 97/16554 PCT/GB96/02696 transformation, using any suitable technique available to those skilled in the art. Furthermore, plants which comprise such cells, and seed therefor, may be produced by crossing suitable parents to create a hybrid whose genome contains the required nucleic acid, in accordance with any available plant breeding technique.
Also according to the invention there is provided a starch-producing plant cell as disclosed having incorporated into its genome a sequence of nucleotides encoding a polypeptide with maltase activity under operative control of-a regulatory sequence for expression of the encoded polypeptide. Expression of the polypeptide results in depletion of malto-oligosaccharides in the cell, which in turn results inaction of GBSSI on amylopectin as opposed to amylose to produce modified amylopectin. A further aspect of the present invention provides a method of making such a plant cell involving introduction of a vector comprising the sequence of nucleotides into a plant cell. Such introduction may be followed by recombination between the vector and the plant cell genome to introduce the sequence of nucleotides into the genome. The polypeptide encoded by the introduced nucleic acid may then be expressed in the cell and descendants thereof, including cells in plants regenerated from transformed material. A gene stably incorporated into the genome of a plant is passed from _ CA 0223~619 1998-04-22 generation to generation to descendants of the plant, so such decendants should show the desired phenotype.
The present invention also provides a plant comprising a plant cell as disclosed. Such a plant produces modified amylopectin and starch as disclosed.
A plant according to the present invention may be one which does not breed true in one or more properties.
Plant varieties may be excluded, particularly registrable plant varieties according to Plant Breeders' Rights. It is noted that a plant need not be considered a "plant variety" simply because it contains stably within its genome a transgene, introduced into a cell o~ the plant or an ancestor thereof.
In addition to a plant, the present invention provides any clone of such a plant, seed, selfed or hybrid progeny and descendants, and any part of any of these, such as cuttings, seed. The invention provides any plant propagule, that is any part which may be used in reproduction or propagation, sexual or asexual, including cuttings, seed and so on.
The present lnvention is particularly beneficial for use in plants such as crop plants, including cereals and pulses, maize, wheat, potatoes, tapioca, rice, sorgum, millet, cassava, barley, pea and other root, tuber or seed crops, in principle any plant which is a source of starch.
The amylopectin and/or starch may be extracted CA 0223~619 1998-04-22 W O 97/16~54 PCT/GB96/02696 from plants according to the invention following its production in cells of the plant. Starch and/or amylopectin may be obtained using any available tecnique. For instance, potato starch is easily separated from tubers and in early nineteenth-century households was commonly prepared for domestic use. On an industrial scale, starch may be obtained from potatoes using, for example, a method along the following lines: The potatoes are disintegrated in a stream of water in a rapidly rotating vertical hammer-mill enclosed by a cylindrical perforated screen.
Through this the pulp is forced and passes into a series of centrifugal rotating sieves. The starch suspension which has passed through the sieves proceeds, with the addition of wash water, through a number of centrifugal separators to remove soluble impurities, then through a vacuum filter, a preliminary conveyor-drier with a countercurrent of air at about 145 ~C, followed by a series of blowers with cyclone separators, also at 145 ~C, and a final cool-air blower with cyclone.
A further aspect of the present invention thus provides starch or amylopectin obtained or obtainable from a plant or plant cell according to the invention as disclosed.
The starch or amylopectin removed from a plant may be purified and may be formulated into a composition. A composition containing such starch or CA 0223~619 1998-04-22 amylopectin may include one or more, i.e. at least one, additional component. Such compositions include food formulations, industrial formulations etc. Uses of starches and compositions containing starch have been discussed above.
"Malto-oligosaccharide" includes individually or collectively any ~-1,4 or ~-1,4,~1,6 glucan that is soluble within the cell rather than forming part of a polymer within the starch granule, including each of the mono- and oligomers investigated experimentally herein, such as maltose, maltotriose, maltotetraose, maltopentaose, maltohexaose and/or maltoheptaose.
Reference to malto-oligosaccharide "content" is to composition (quality) and/or level (quantity).
It should be noted that terms such as "modulating" and "altering" are used in relation to control being exercised over something as a result of human intervention. With respect to the level of MOS
in a cell, the intervention may result in an increase or decrease in the level of MOS as compared with the level in the absence of the intervention, i.e. in comparison with equivalent wild-type cells, e.g. of plants of the same species. (Cells which are wild-type in respect of MOS levels may of course not be wild-type in every respect.) Instead of modulating the level of MOS in a cell by way of reduction or depletion, the level may be increased in order to direct action of GBSSI from CAW O 97/16~54 PCT/GB96/02696 amylopectin to amylose.
Any mechanism that increases the concentration o~
MOS in the amyloplast of developing storage organs may bring about an increased synthesis of amylose by increasing the availability of primer for GBSSI
activity or the affinity of GBSSI for amylose relative to amylopectin within the starch granule. This results in an increased ratio of amylose to amylopectin in the starch, and may also af-fect the size and/or structure of amylose molecules. An increased concentration of MOS may be brought about by the introduction into the amyloplast of any enzyme capable of the generation of MOS.
These glucans can be generated in vivo by several enzymes known to be present in developing starch-storing organs, namely ~-amylase, ~-amylase, disproportionating enzyme, debranching enzyme and starch phosphorylase. Glucans can also be generated by other enzymes, including debranching enzymes, starch phosphorylases and amylosucrases of bacteria.
The first four of these enzymes can generate glucans by cleavage or rearrangement of nascent glucan chains synthesised by starch synthase and starch-branching enzyme. Starch phosphorylase can generate glucans ~rom glucose 1-phosphate (Steup 1988, 1990; Takaha et al. 1993).
Typically preferred enzymes for use in this aspect of the invention have low or negligible -CA 0223~619 1998-04-22 activity against intact starch granules, and may be a starch phosphorylase or a ~-amylase. Obviously, a pH
optimum within the range of pH likely to occur within the all cytoplasm (typically 6.5-7.8) is preferred.
Methods for identification and characterisation of activities of these enzymes are extensively discussed by Steup (1990). Genes for plastidial isoforms of phosphorylase, ~-amylases, ~-amylases, disproportionating enzymes and debranching enzymes have been cloned (Nakano et al. 1989, Lin et al. 1991, Sonnewald et al. 1995, Yoshida et al. 1992, Siggens 1987, Monroe et al. 1991, Kreiss et al. 1987, Takaha et al., 1993, James et al. 1995~. DNA sequences of these enzymes are described in the references cited above and in databases, and may be used to clone genes encoding these and further enzymes, for instance using methods described above for ~-glucosidases. The activity in the amyloplast of a storage organ may be increased by introduction of one of these genes by any appropriate method of plant transformation, as discussed.
For instance, this may be achieved by the Agrobacterium rhizogenes-based method used by van der Lei3 et al (1991) for the successful introduction of the amf gene product into the amyloplast of potato tubers carrying a mutation at the amf locus. The gene used for transformation should preferably be from a species different from that being transformed, to CA 0223~619 1998W O 97/16554 PCT/GB96/02696 . 30 avoid potential problems of co-suppression. Genes for B-amylase have been cloned from plants and bacteria (eg. Yoshida et al. 1992, Siggens 1987, Monroe et al.
1991, Kreiss et al. 1987) hence this activity may be introduced into the amyloplast of a storage organ through the use of any of these genes in any appropriate method of plant transformation. The products of these genes are typically targeted to cell compartments other than the plastid in plants, and outside the cell in bacteria. Preparation of a suitable construct for introduction of B-amylase activity into the amyloplast advantageously may therefore involve selection of a part of the protein that has catalytic activity but lacks targeting sequences. Information about the structure-function relationships of the protein enables a person skilled in the art to select such a region of the protein (eg.
Janacek 1994, Kawazu et al. 1987). Construction and int-roduction of an appropriate plasmid for expression of a B-amylase in the amyloplast may be achieved using any suitable technique available to the person skilled in the art, as discussed above e.g. for ~-glucosidase.
Thus, the present invention relates to increasing the level of MOS in a plant cell in various aspects which are analogous to those disclosed and discussed above in relation to reducing MOS levels.
Activity of a glucan-synthesizing enzyme in a cell or tissue extract or enzyme within a purified CA 0223~619 1998-04-22 starch granule may be identified by ability of the enzyme, extract or granule to incorporate the glucosyl moiety from ADPG into a glucan via an ~-1,4 linkage.
The preferred methods of assay are described by Jenner et al. (1994).
Modification of the activity or nature of the granule bound starch synthase activity of a cell may be used to alter the extent or the nature of the change in starch stucture brought about by alteration of MOS content in the cell.
Genes encoding GBSSI from many plant species have been cloned (see Ainsworth et al., 1993), and sequences are available. DNA sequences may be used by a person skilled in the art to clone a GBSSI gene from any suitable species using suitable methods, e.g. as discussed above.
These sequences may be introduced into a plant in such a way as to increase or decrease or alter the nature of the granule-bound starch synthase activity via any suitable transformation technology, again discussed above. Increases may be brought about by introduction of a gene encoding the endogenous enzyme.
Decreases may be brought about through introduction of the gene encoding the endogenous enzyme in an antisense orientation. Alteration of the nature of the enzyme may be brought about by the introduction of a gene encoding a GBSSI or a similar protein from another species, or a gene that has been subjected to CA 0223~619 1998-04-22 ~'O 97/16554 PCT/GB96/02696 mutation such that the properties of the GBSSI it encodes have been modified. A modified GBSSI or a GBSSI from another species may be introduced into a wild-type plant such that the introduced protein is synthesised in addition to the endogenous GBSSI, or it may be introduced into a cell in which endogenous GBSSI activity has been reduced or eliminated through mutation of the expression of antisense RNA.
The present invention will now be illustrated and exemplified with reference to experimental results and the accompanying figures. Further aspects and embodiments of the present invention, and modifications of those disclosed herein, will be apparent to those skilled in the art.
T~E FIGURES:
Figure la: Elution of solubilised pea starch from a column of Sepharose CL-2B. ~ = absorbance at 595 nm of fractions mixed with iodine. ~ = wavelength of maximum absorbance of fractions mixed with iodine Figure lb: Elution of 14C from a column of Sepharose CL-2B loaded with the methanol/KCl-insoluble products of incubation of isolated starch granules from pea embryos with ADP[U-14C]glucose. ~ =
incubation for 1 h. ~ = incubation for 0 h (control).
dps: disintegrations per second.
Figure 2: Effect of debranching with isoamylase CA 0223~619 1998-04-22 on elution profile of 14C from a column of Sepharose CL-2B. Two samples of isolated starch granules from pea embryos were incubated with ADP[U-14C]glucose for 1 h. Methanol/KCl-insoluble products were then incubated with isoamylase (~), or not treated further (--) Figure 3: Comparison of the incorporation of 14C
into methanol/KCl-insoluble products after incubation of starch from wild-type embryos (-) and lam mutant embryos (n) with ADP[U-14C]glucose for 1 h.
Figure 4: Comparison of the granule-bound proteins of wild-type and lam mutant pea embryos.
Starch granules were boiled in SDS-containing sample buffer and centrifuged, and the supernatant was subjected to SDS-polyacrylamide gel electrophoresis as described by Smith (1990). Tracks 1 and 8 = molecular weight markers (sizes indicated in kDa). Tracks 2-4 =
starch from embryos from three different pods of wild-type peas. Tracks 5-7 = starch from embryos from three different pods of lam mutant peas. tracks 2-7 all contain protein from the same weight of starch.
Figure 5: Effect of heat-stable soluble compounds from plant extracts on incorporation of 14C
from ADP[U-14C]glucose by starch granules. Freshly 25 harvested pea embryos (250-350 mg) were homogenised in a mortar in 100 mM Mops (pH 7.2), 5 mM MgCl2, 50 ml.1~
glycerol, 2 mM DTT, 1 g 1-l bovine serum albumin The homogenate was either used directly (unwashed starch CA 0223~619 1998-04-22 granules) or 1-ml aliquots o~ the homogenate were centrifuged at 10000 g for 5 min to give a supernatant containing soluble material and a pellet containing starch granules. The supernatant was removed and the pellet was washed three times by resuspension in homogenisation medium, followed by centrifugation at 10000 g for 5 min and then resuspended in homogenisation medium to give a final volume of 1 ml.
Samples of washed (-) and unwashed (O) starch granules were incubated for 1 h with ADP[U-l4C]glucose and the methanol/KCl-insoluble products were subjected to Sepharose CL-2B chromatography.
Figure 6: Effect of ~-glucosidase treatment on the stimulatory effect of soluble extract on amylose synthesis. Isolated starch granules and treated and untreated supernatant ~ractions were those described in Table 2. The products of assays of granules suspended in Mops medium (-), treated supernatant (O) and untreated supernatant (O) were subjected to chromatography on Sepharose CL-2B
Figure 7: Effect of malto-oligosaccharides on incorporation of 14C from ADP[U-l4C]glucose into methanol/KCl-insoluble products by starch granules from wild-type pea embryos. Incubations were for 1 h and contained 100 mM maltose (O), 100 mM maltotriose (o) 100 mM maltohexaose (x) or no additions (-).
Figure 8: Comparison of the effects of maltotriose on incorporation of 14C from ADP[U-CA 0223~619 1998-04-22 14C]glucose by starch granules from wild-type pea embryos (O = with maltotriose, ~ = without maltotriose) and lam mutant pea embryos (O = with maltotriose, ~ = without maltotriose) Figure 9: Effect of malto-oligosaccharides on incorporation of 14C from ADP[U-14C]glucose into methanol/KCl-insoluble products by starch granules from developing potato tuber. Incubations were for 1 h and contained 100 mM maltotriose (O) or no additions 10 (--).
Figure 10: Elution of debranched, 14C-labelled starch from a column of Sepharose CL-4B. Samples of isolated starch granules from pea embryos and starch granules which had been incubated with ADP[U-15 14C]glucose for 1 h were incubated with isoamylase prior to loading onto the column. Elution of unlabelled sample, as absorbance at 595 nm of fractions mixed with iodine (-); and elution of 14C-labelled, methanol/KCl-insoluble products from sample 20 incubated with ADP[U-14C]glucose (O).
Figure 11: Effect of pre-treatment with ~-glucosidase on the stimulatory influence of soluble extracts of potato tuber on amylose synthesis. Two, replicate 5-g samples of developing tuber were ~ 25 prepared. One was used for isolation of starch granules as described in Experimental procedures. The other was extracted in a mortar in a total of 10 ml of 50 mM sodium acetate (pH 5.5) with 0.5 g CA 0223~619 1998-04-22 polyvinylpolypyrrolidone. After centrifugation, the supernatant (soluble extract) was boiled for 5 min then samples were incubated for 18 h with or without 1.25 unit ml~l ~-glucosidase (yeast) at 35~C. After boiling again, all samples were brought to pH 7. The starch granules were resuspended at 25 mg ml~l in Medium A (~ glucosidase-treated soluble extract (O) or untreated soluble extract (~) and incubated for 1 h with ADP[U-l4C]glucose. The methanol/KCl-insoluble products were subjected to chromatography onSepharose CL-2B.
Figure 12: Comparison of the effects of maltotriose on incorporation of 14C from ADP[U-l4C]glucose by starch granules from wild-type and lam mutant pea embryos. Wild-type: ~, with 100 mM
maltotriose; ~, without maltotriose lam mutant-: O, with 100 mM maltotriose; ~, without maltotriose Figure 13: Effect of malto-oligosaccharides on incorporation of 14C from ADP[U-l4C]glucose into methanol/KCl-insoluble products by starch granules from developing potato tuber. Incubations contained 100 mM maltotriose (~) or no additions (-).
All documents mentioned herein are lncorporated by reference.
.RT~T..c AND METHODS
Plant material CA 0223~619 1998-04-22 Peas were of a round-seeded line ( Pisum sa tivum L., BC1/12 RR: see Smith 1990 for derivation of this line) or a low-amylose (lam) mutant line (SIM 503) derived from the round seeded line (Denyer at al.
1995a). Both were obtained from Dr. Cliff Hedley and Dr. Trevor Wang, John Innes Centre, Norwich. Plants were grown as described by Denyer et al. (1995a).
Potatoes (Solanum tuberosum L. cv Desiree) were grown as described by Edwards et al. (1995).
Preparation o~ starch Starch was prepared from developing pea embryos essentially according to Smith (1990). Approximately 1-3 g of embryos of fresh weight 200-400 mg was homogenised in a mortar with 5-15 ml 100 mM Tris-acetate (pH 7), 0.5 M NaCl, 1 mM dithiothreitol (DTT), 1 mM ethylenediaminetetraacetic acid (EDTA) at 4~C.
The homogenate was filtered through two layers of Miracloth (Behring Diagnostics, La Jolla, CA, USA), and the residue was washed in the filter cloth with a further 5-15 ml of extraction medium. The combined filtrate was stirred at 4~C for 30 min and then subjected to centrifugation at 2000 g for 10 min. The supernatant and the green material from the surface of the pellet were discarded and the pellet was resuspended in 10 ml extraction medium. This centrifugation and resuspension procedure was repeated, once with extraction medium and three times CA 0223~619 1998-04-22 W O 97/16~54 PCT/GB96/02696 with 50 mM Tris-acetate (pH 8), 1 mM DTT, 1 mM EDTA.
The pellet was resuspended in acetone cooled to -20~C
and allowed to settle for 15 min, and then the supernatant was discarded. This acetone wash was repeated twice more and the washed starch was dried under air at room temperature. The starch was either used immediately or stored at -20~C for up to 2 months.
Starch was prepared from developing potato tubers (each 10-100 g fresh weight) essentially as described above for pea embryos except that the extraction medium was-50 mM Tris-acetate (pH 8), 1 mM DTT, 1 mM
EDTA, stirring at 4~C was omitted and the total number of washes in extraction medium was 3-4.
Incubation of gr~n~-l t~S with ADPglucose Starch granules were resuspended at lmg per 40 ~l in 100 mM 3-(N-morpholino)propanesulphonic acid (Mops, pH 7.2), 5 mM MgCl2, 50 ml.l 1 glycerol, 2 mM DTT, 1 g 1-l bovine serum albumin. Each incubation contained 10 ~ul starch suspension and 90 ,ul 100 mM Bicine (pH
8.5), 25 mM potassium acetate, 10 mM DTT, 5 mM EDTA, 1 mM ADP[U-14C]glucose (Amersham International, Bucks, UK) at 18.5 GBq.mol~1 and was incubated at 25~C for 1 hour. The incubation was terminated either by heating for 2 min at 90~C followed by the addition of 3 ml 750 ml.l~1 aqueous methanol containing 10 g.l~1 KCl (methanol-KCl) or by the addition of methanol-KCl CA 0223~619 1998-04-22 alone. After incubation at room temperature for a minimum of 5 min, the precipitated starch was collected by centrifugation at 2000 g for 5 min. The supernatant was discarded and the pellet was resuspended in 0.3 ml distilled water. This methanol-KCl wash, centrifugation and resuspension was repeated twice more except that after the final centrifugation the distilled water was omitted and the pellet was dried in air at room temperature for a m; n;mllm of 10 min. The washed starch pellet was dissolved in 50 ,ul of 1 M NaOH, diluted with 50 ~l distilled water, and subjected to gel filtration chromatography.
Isoamylase digestion Starch granules were incubated with ADPglucose and washed with methanol-KCl as described above. The dried starch pellet was resuspended in 25 ul 50 mM
sodium acetate (pH 3.5) containing 4000 units isoamylase ~Sigma, Poole, Dorset, UK) and incubated at 37~C for 24 h. The starch was then dissolved in 50 ul 1 M NaOH, diluted with 25 ~l distilled water, and subjected to gel filtration chromatography.
Gel ~iltration chromatography on Sepharose CL-2B
Samples were either unlabelled starch which was dissolved in 1 M NaOH at 20 mg. ml~l and diluted with distilled water to 0.5 M NaOH or l4C-labelled starch prepared as described above. A 50-~l sample of CA 0223~619 1998-04-22 dissolved starch was applied to a column (0.5 cm i.d.
x 30 cm) of Sepharose CL-2B equilibrated with 100 mM
NaOH, and eluted with this solution (Denyer et al.
1995a). Fractions of 0.15-0.17 ml were collected at the rate of one fraction per minute. Glucans in fractions from unlabelled samples were detected by their reaction with iodine as described in Denyer et al. (1995a). Radioactivity in fractions from samples containing labelled glucans was determined by liquid scintillation counting on a Wallac 1410 counter (Wallac UK, Milton Keynes, UK) using 1 or 3 ml HiSafe II liquid scintillation fluid (Beckman Ltd., High Wycombe, Bucks, UK) per fraction.
SDS-polyacryl ;~ gels As described in Denyer et al. (1995).
As~ay o~ granule-bound starch synthase activity Assays contained 100 mM Bicine (pH 8.5), 25 mM
potassium acetate, 10 mM DTT, 5 mM EDTA, 1 mM ADP[U-14C]glucose (Amersham International, Bucks, UK) at 2.3 GBq mol-1 and 10 ul of a suspension of starch granules in a ~inal volume of 100 ul. Assays were incubated at 25~C for 15 min and then heated to 90~C for 2 min.
Controls were heated to 90~C immediately after the addition of starch granules to the assay. All assays and controls were duplicated. Starch was precipitated with methanol-KCl and washed as described above -CA 0223~6l9 l998-04-22 (Incubation of starch granules with ADPglucose) except that the final pellets were dissolved in 0.3 ml of distilled water followed by 3 ml HiSafe II liquid scintillation fluid. Radioactivity was determined by liquid scintillation counting.
RESULTS
Identification o~ the products o~ GBSS
The starch synthase activity of starch granules isolated from pea embryos was measured as the incorporation of 14C from ADP[U-14C]glucose into material which was insoluble in 750ml.1 l methanol containing lOg.l~1 KCl (methanol/KCl). This activity was specific for ADPglucose (there was almost no activity with UDPglucose - at lmM the activity was less than 3% of that with ADPglucose at the same concentration) and the incorporation was linear with respect to time for at least lh. The 14C-labelled methanol/KCl-insoluble material was completely solubilised after incubation with amyloglucosidase (not shown), showing that the products of the reaction were glucans (~-1,4, ~-1,6 linked). In control assays, which were terminated immediately after the addition of the substrate, incorporation of-14C into glucans was minimal (less than 3% of that in assays which were incubated for lh).
Sepharose CL-2B chromatography of pea starch results in a clear separation of the amylose and CA 0223~619 1998-04-22 amylopectin components (Fig. la). Amylopectin is the first peak of glucan to elute, and amylose the second (Denyer et al. 1995a). When the methanol/KCl-insoluble products from incubation of isolated starch granules with ADP[U-l4C]glucose were subjected to chromatography on a column of Sepharose CL-2B, 14C
eluted predom,n~ntly in the amylopectin peak (Fig.
lb). In seven experiments, the average recovery of 14C
in the amylopectin peak as a percentage of the total 14C eluted from the column was 78 + 12% (mean ~ SD).
The total 14C recovered in the fractions eluting from the column in these and subsequent experiments was 70-100~ of that applied to the column, hence there were no major losses of labelled products on the column.
To investigate whether the 14C co-eluting with amylopectin was in amylopectin or in high-molecular-weight amylose molecules, the products were treated with isoamylase to debranch glucans prior to application to the column. After isoamylase treatment the 14C eluted much later from the column (Fig. 2), indicating a lower molecular weight. In control treatments with buffer instead of isoamylase, the position of elution of 14C was unaltered (data not shown). These results are consistent with incorporation of 14C glucose via GBSS into the branches of amylopectin molecules rather than into linear polymers.
The starch granules used in these experiments CA 0223~619 1998-04-22 were prepared by washing insoluble extracts of developing pea embryos several times in aqueous media, then in cold acetone followed by drying in air and storage at -20~C for up to two months before being assayed. To determine whether these preparation or storage methods influenced the type of products made by the GBSSs, granules prepared by the following alternative methods were assayed: 1) freshly-prepàred granules which had not been stored at -20~C and 2) freshly-prepared granules which were washed with aqueous media but not washed with acetone or air~
dried. In both of the above experiments the elution profile of 14C was essentially the same as that shown in Fig lb: the incorporation was very largely into amylopectin.
Hylton et al. (1995) found that mechanically-damaged starch granules from barley endosperm had a higher GBSS activity than intact granules, and that most of the increase~in activity was due to isoforms other than GBSSI. In the light of this result we investigated whether in our experiments the pattern of incorporation of glucose was affected by damage to the granules. Granules were prepared with the minimum of mechanical damage by chopping the developing pea embryos with a razor blade into extraction medium rather than by grinding in a mortar. The activity (per mg starch) of granules prepared from chopped pea embryos was approximately half that of granules CA 0223~619 1998-04-22 W~D97/16554 PCT/GB96/02696 prepared by grinding. However, there was no change in the nature of the products which were synthesised (not shown). There was no change in the pattern of incorporation of 14C into polymers: most of the incorporation in the granules prepared by chopping rather than grinding was into amylopectin (not shown).
Analysis o~ the size o~ the l4C-l~ll~ amylopectin ~h A ; n .~
To investigate the average Length of amylopectin chains into which 14C was incorporated, the products of the incubation of pea starch granules with ADP[U-l4C]glucose were debranched with isoamylase and subjected to chromatography on a column of Sepharose CL-4B. The first peak of glucan to elute from the column in the experiment shown in Figure 10 consisted of amylopectin which had not been completely debranched. Glucan eluting later from the column consisted of chains of debranched amylopectin.
Comparison of the elution profiles of 14C-labelled and unlabelled amylopectin chains showed that the peak of the former eluted earlier than the latter. This suggests that the chains elongated via starch synthases during the incubation were considerably longer than the average chains in the amylopectin molecules.
Comparison of -~tarch ~rom wild-type and l~m mutant CA 0223~619 1998-04-22 embryos To investigate whether the observed elongation of amylopectin was due to the activity of GBSSI, GBSSII
or both of these isoforms, we compared the incorporation of 14C-glucose from ADP[U-l4C]glucose into starch from wild-type and lam mutant pea embryos.
Starch granules from lam mutant embryos lack GBSSI, therefore incorporation into these granules must be via GBSSII alone. The incorporation into granules from lam mutant embryos was entirely into the amylopectin fraction (Figure 3). This shows that GBSSII of pea embryos can elongate amylopectin branches within the granule.
As reported previously, the total incorporation of 14C glucose into granules of lam mutant embryos was lower than granules of wild-type embryos on a starch basis (Denyer et al. 1995a). To discover whether this reduction in incorporation was due solely to the absence of GBSSI, or whether the mutation also resulted in a reduction in the amount of GBSSII, granule-bound proteins from both starches were extracted and compared on SDS-polyacrylamide gels (Fig 4). The amount of GBSSII protein per mg of starch was the same in the wild-type and the mutant. Assuming - 25 that the activities of the GBSSs were not grossly affected by structural differences between the starches, this suggests that the difference between the starches of wild-type and lam embryos in their -CA 0223~619 1998-04-22 ability to incorporate glucose from ADPglucose into amylopectin is attributable to the activity of GBSSI.
The effect of the soluble fraction o~ storage organs on the products of the GBSSs The above experiments show that GBSSI in isolated starch granules transfers glucose from ADPglucose largely to amylopectin rather than to amylose molecules. Since this isoform is responsible for the synthesis of amylose in vivo, some factor(s) present in vivo but not in isolated starch granules may be required for amylose synthesis. To investigate whether soluble factors required for amylose synthesis had been washed out of the starch granules during their preparation, we compared the methanol/KCl-insoluble products of incorporation from ADP[U-14C]glucose by crude homogenates of developing pea embryos (containing both soluble and insoluble fractions) and washed starch granules derived from the homogenates (Figure 5). Crude homogenates gave a higher total incorporation of l4C-glucose than washed starch granules, due to an appreciably greater incorporation into amylose. When the soluble ~raction derived by centrifugation of crude extracts was added back to the washed starch granules, a stimulation of incorporation into amylose was observed equivalent to the amylose synthesis in crude homogenates. Boiling the soluble extract prior to this addition did not CA 0223~619 1998-04-22 effect its ability to stimulate amylose synthesis, shwoing that the stimulatory factor was heat-stable and suggesting that soluble enzymes were not required (not shown).
- 5 We investigated whether developing potato tubers also contained soluble factors which could stimulate the activity of GBSS. GBSS activity in crude homogenates of tuber is considerably greater than that in washed starch granules derived from the same homogenate. As with pea embryos, the addition of boiled, soluble extract to the washed starch granules stimulates the GBSS activity (Table 1) and promotes the synthesis of amylose (Figure 11).
Taken as a whole, these experiments suggest that soluble extracts of pea embryos and potato tubers contain non-enzymic factors which stimulated amylose synthesis in the granule. Leloir et al. (1961) found that GBSS activity was stimulated by the presence of maltose, maltotriose or maltotetraose and presented evidence to suggest that these malto-oligosaccharides could act as substrates for GBSSs in granules isolated from Phaseolus vulgaris. Although the work of Leloir et al. involved the transfer of glucose from UDPglucose, an activity which is not present to any - 25 significant extent in our preparations of starch granules, it seemed possible that the stimulatory factors in our soluble extracts are malto-oligosaccharides which act as primers for amylose CA 0223~619 1998-04-22 W ~ 97/16554 PCT/GB96/02696 synthesis. To investigate this, boiled, soluble extracts of potato tuber were treated with ~-glucosidase (maltase) to remove malto-oligosaccharides. This treatment eliminated the ability of the extracts to stimulate GBSS activity of isolated starch granules, and to promote incorporation of 14C into amylose (Table 2, Figure 6).
In three separate experiments, the granule-bound starch synthase activity relative to that of starch granules resuspended in Medium A was 154.-3% + 16.5%
(mean ~ SD) for starch granules resuspended in untreated soluble extract and 109.8~ + 8.9% (mean +
SD) for starch granules resuspended in ~-glucosidase-treated soluble extract. The results from the analysis of one of these experiments is shown in Figure 11. Taken as a whole, these experiments suggest that soluble extracts of pea embryos and potato tubers contain malto-oligosaccharides which can stimulate amylose synthesis in starch granules.
We therefore investigated whether purified malto-oligosaccharides could promote amylose synthesis by isolated granules. The results are presented below.
The effects o~ malto-oligo-~h~ides on GBSS activity ~hen supplied to isolated starch granules from pea embryos, a range of small malto-oligosaccharides, from maltose to maltohexaose, stimulated the incorporation o~ 14C-glucose from ADP[U-l4C]glucose CA 0223~619 1998-04-22 into material eluting from Sepharose CL-2B in the same position as, or slightly after amylose. Incorporation into amylopectin was reduced (Figure 7), and incorporation into material eluting from a Sepharose CL-2B column in the same position as, or slightly after, amylose was greatly stimulated. Maltoheptaose and a mixture of malto-oligosaccharides with from four to ten glucose units had a similar effect (data not shown). With maltose, the effect was apparent at concentrations of lOmM, and was fully saturated at lOOmM. Neither lOOmM glucose nor lOOmM cellobiose had any effect on incorporation, showing that the stimulatory effect was specific for malto-oligosaccharides (data not shown).
To determine whether the synthesis of amylose in the presence of malto-oligosaccharides was due to the activity of GBSSI, GBSSII or both, the products formed in the presence of maltotriose by granules from wildtype and lam mutant embryos were compared (Figure 8 and Figure 12). Maltotriose had no effect on the products synthesised by starch granules from lam mutant embryos, showing that GBSSII alone could not synthesise amylose in the presence of malto-oligosaccharides. The amylose synthesis observed in wild-type granules in the presence of malto-oligosaccharides is therefore likely to be due to the activity of GBSSI.
CA 0223~619 1998-04-22 W ~ 97/16554 PCT/GB9~/02696 The e~fect of malto-oligo-Q~r~h~ides on the GBSS
activity o~ starch from potato tubers We compared the effects of malto-oligosaccharides on pea starch with the effects on starch isolated from developing potato tubers. The Sepharose CL-2B column was less effective in separating amylose and amylopectin from potato starch than from pea starch (not shown) but it was nonetheless clear that in the abse~ce of maltotriose, incorporation of 14C from ADP[U-14C]glucose was largely into the amylopectin peak. See Figure 13. In the presence of maltotriose, the incorporation into amylopectin was reduced dramatically and there was an increase in incorporation into amylose (Figure 9). These results are similar to those obtained with pea starch and were consistent with the idea that GBSSI of potato starch elongates amylopectin in the absence o~ maltotriose and synthesises amylose in the presence of maltotriose.
DISCUSSION
Our results show that both GBSSI and GBSSII of developing pea embryos elongate glucans within starch granules. GBSSI can elongate the branches o~
amylopectin as well as elongating maltose and higher oligomers o~ glucose. GBSSII can elongate amylopectin but apparently cannot elongate short malto-oligosaccharides. Thus only GBSSI can initiate the , CA 0223~6l9 l998-04-22 synthesis of amylose. We cannot rule out from our present studies the possibility that GBSSII could contribute to the elongation of amylose, once these molecules have reached a certain size.
The properties of the GBSSI of developing pea embryo described in this paper should represent the properties of this class of starch synthases generally. Baba et al. (1987) showed that granules isolated from sweet potato tubers incorporated 14C from ADP[U-14C]glucose primarily into amylopectin. Malto-oligosaccharides were not supplied in these experiments. Leloir et al. (1961) showed that malto-oligosaccharides could act as primers for starch synthesis in granules from developing beans. We have shown that malto-oligosaccharides are required to stimulate amylose synthesis in isolated granules from potato tubers as well as pea embryos.
Starches from many starch storing organs possess GBSSs very similar in size, antigenic properties and/or sequence to GBSSII of pea. The properties of all members of the GBSSII class are likely to be similar, so elongation of amylopectin via these isoforms within the granules of starches other than pea may also occur. However, there is variation between starches from different sources in the types and numbers of GBSSs other than GBSSI (Smith et al.
1995). At present, we have no information on the ability of GBSSs other than GBSSI and GBSSII to CA 0223~619 1998-04-22 ~TO 97/16554 PCT/G B96/02696 elongate amylopectin within the granule. Starches from different sources also vary in the extent to which GBSSs other than GBSSI contribute to the total GBSS activity. For example the activity of GBSSII is very low compared to the activity of GBSSI in potato tubers (Edwards et al. 1995). This may account for the much lower incorporation into amylopectin in the presence of maltotriose in potato starch than in pea starch (Figs 8 and 9). Thus the contribution of GBSSs to amylopectin synthesis within the granule may differ between starches because both the total activity and the properties of these enzymes may vary.
In isolated granules, the overall activity of GBSSI and the nature of its products depends upon the availability of malto-oligosaccharides. We have demonstrated the presence in crude extracts of pea and potato of compounds which are susceptible to degradation by ~-glucosidase, and which stimulate amylose synthesis in isolated granules. These malto-oligosaccharides may be produced in vivo by the actionof starch-degrading enzymes. It has long been known that such degradative enzymes are present during starch synthesis and some of these have been shown to be plastidial. Our results suggest that one role of the degradative enzymes may be to produce primers for amylose synthesis.
CA 0223~619 1998-04-22 GBSS activity (,umol.min~l.g~l FWT) Homogenate 0.171, 0.198 Washed pellet 0.063, 0.093 Washed pellet + boiled ~u~ al~lll 0.149, 0.147 GBS5 activi ty in fractions of crude extracts of devel oping po ta to tubers .
Samples o~ developing tubers were homogenised, and washed pellet (containing starch granules) and supernatant (containing soluble material) ~ractions 15 were prepared as described in Figure 5 for pea embryos Starch synthase activity was assayed in the homogenate and the supernatant, and the latter value subtracted ~rom the ~ormer to give GBSS activity in the homogenate. Hal~ of the washed pellet was 20 resuspended in 1.5 ml extraction medium and hal~ in 1.5ml boiled supernatant, and both samples were assayed ~or starch synthase activity. Boiled supernatant contained no detectable starch synthase activity. In these experiments, amylopectin (potato;
25 Sigma, Poole, Dorset, UK) was included in the assays at 5 mg ml~1. Values are ~or samples ~rom two, separately-extracted tubers.
.
SUBSTilUTE SHLET (RULL 26) CA 0223~619 1998-04-22 W'~97/16554 PCT/GB96/02696 ~ 54 GBSS activity (nmol.min~l.mg~l starch) buffer 0.708 u~ L~d supernatant 1.170 treated supernatant 0.751 Ef~ect of ~-glucosidase treatment on stimulation of GBSS activity by crude extracts of developing potato tubers.
Two, replicate samples, each of 5 g, of developing tuber were prepared. One was used ~or isolation of acetone-washed starch granules as described in Materials and Methods. The other was extracted in a mortar in a total of 10 ml of 50 mM Na acetate (pH 5. 5) with 0. 5 g polyvinylpolypyrrolidone.
After centrifugation, the supernatant was boiled for 5 min then samples were incubated overnight with or without 1. 25 unit.ml~ -glucosidase (yeast) at 35~C
A~ter boiling again, all supernatant samples were brought to pH 7 and used to resuspend starch granules (prepared from the other sample of tuber) for assay.
Buf~er = starch resuspended in Mops medium as described in Materials and Methods, untreated ~upernatant = supernatant incubated without ~-glucosidase, treated supernatant = supernatantincubated with ~-glucosidase.
SUBSTITUTE SHEET (RULE 26) CA 0223~619 1998-04-22 Ainsworth et al. (1993) Plant Mol. Biol. 22, 67-87.
Baba et al, (1987). Starke 39, 52-56 Bernfeld P (1951) Enzymes of starch degradation and synthesis. In: Advances in Enzymology Vol. 12. New York, Interscience Publishers. pp 379-428 Bevan M (1984) Nucl. Acids Res. 12, 8711-8721 Cornish-Bowden A (1995) Fundamentals of enzyme kinetics. London, Portland Press Denyer et al, (1995a). L. Plant Cell Env. 18, 1019-Denyer et al, (1995b). Planta 196, 256-265 Denyer et al, (1993). Plant J. 4, 191-198 Edwards et al, (1995). Plant J. 8, 283-294 Federoff et al, (1982). J. Bact. 149, 1064-1070 Frohman et al. GR (1988) Proc. Natl Acad. Sci. USA 85, Frydman et al, (1967). J. Biol. Chem. 242, 312-317 Guerineau F, Mullineaux P (1993) Plant transformation and expression vectors. In: Plant Molecular Biology Labfax (Croy RRD ed) Oxford, BIOS Scientific Publishers, pp 121-148 Hong SH, Marmur J (1986). Gene 41, 75-84 Hylton et al, (1995). Planta, in press James et al. (1995) Plant Cell 7, 417-429 Jenner et al. (1994) Aust. J. Plant Physiol. 21, 17-22 Kawazu et al, (1987). J. Bact. 169, 1564-1570 Kelly CT, Fogarty WM (1983). Process Biochem. May-CA 0223~619 1998-04-22 June, pp 6-12 Klosgen RB, Weil J-H (1991) Mol. Gen. Genet. 225, 297-van der Leij et al, (1991). Theor. Appl. Genet 82, Kreis et al, (1987). Eur. J. Biochem. 169, 517-525 Leloir et al, (1961). J. Biol. Chem. 236, 636-641 Lin et al, (1991). Plant Physiol. 95, 1250-1253 Lowry OH, Passonneau JV (1971) A flexible system of enzymatic analysis. New York, Academic Press Macdonald FD, Preiss J (1983). Plant Physiol. 73, 173-Marshall et al. (1996) Plant Cell 8, 1121-1135 Martin C, Smith AM (1995). Plant Cell 7, 971-985 Monroe et al, (1991). Plant Physiol. 97, 1599-1601 Nakano et al, (1989). J. Biochem. 106, 691-695 Needleman et al. (1978) Biochem. J. 17, 4657-4661 Shewmaker et al, (1994). Plant Physiol. 104, 1159-1166 Siggens KW (1987). Mol. Microbiol. 1, 86-91 Smith AM (1990). Planta 182~ 599-604 Smith AM, Martin C (1993) Starch biosynthesis and the potential for its manipulation. In: Biosynthesis and manipulation of plant products (Grierson D ed.) pp 1-54. Blackie Academic and ProfessionaL, Glasgow Smith et al, (1995). Plant Physiol. 107, 673-677 Spychalla JP, Bevan MW (1993) Agrobacterium-mediated transformation of potato stem and tuber tissue, regeneration and PCR screening for transformation. In:
CA 0223~619 1998-04-22 Plant Tissue Culture Manual B11 (Gelvin SB, Schilperoot RA eds) Dordrecht: Kluwer Academic Publishers, ppl-18 Sonnewald et al, (1995). Plant Mol. Biol. 27, 567-576 Steup M (1988) Starch degradation. In: Biochemistry of Plants,Vol. 14 (Preiss J ed.) pp 255-296. Academic Press, San Diego Steup M (1990) Enzymes of starch degradation. In:
Methods in Plant Biochemistry, Vol. 3 (Lea PJ ed.) pp 103-128. Academic Press, San Diego Takaha et al, (1993). J. Biol. Chem. 268, 1391-1396 Watanabe et al, (1990). Eur. J. Biochem. 192, 609-620 Yoshida et al, (1992). Gene 120, 255-259
Claims (54)
1. A method of altering the branched .alpha.-glucan content of .alpha.-glucan produced in a plant cell having .alpha.-glucan synthase activity, the method including transformation of a plant cell with nucleic acid encoding .alpha.-glucosidase enzyme activity, whereby the transformed plant cell and descendants thereof express the .alpha.-glucosidase enzyme activity, which activity includes maltase activity but little or no iso-maltase activity and little or no activity against starch granules, thereby depleting cellular malto-oligosaccharide (MOS) content and therefore increasing the branched .alpha.-glucan content of the produced .alpha.-glucan compared with its unbranched .alpha.-glucan content.
2. A method of altering the branched .alpha.-glucan content of .alpha.-glucan produced in a plant cell having .alpha.-glucan synthase activity, the method including transformation of a plant cell with nucleic acid encoding enzyme activity, whereby the transformed plant cell and descendants thereof express the enzyme activity, which activity generates malto-oligosaccharide (MOS) within the cell while having negligible activity against intact starch granules, thereby increasing cellular MOS content and therefore increasing the unbranched .alpha.-glucan content of the produced .alpha.-glucan compared with its branched .alpha.-glucan content.
3. A method according to claim 2 wherein the enzyme activity comprises a disproportionating enzyme.
4. A method according to claim 2 wherein the enzyme activity comprises a starch phosphorylase.
5. A method according to claim 1 wherein said .alpha.-glucosidase enzyme activity is provided by a maltase of Bacillus amylolyticus or the maltase encoded by the MAL6 locus of Saccharromyces carlsbergensis or a mutant, derivative, variant or allele thereof.
6. A method according to any of claims 1 to 5 wherein the .alpha.-glucan synthase activity is Granule Bound Starch Synthase I
(GBSSI) activity.
(GBSSI) activity.
7 A method according to claim 6 wherein the cell has an .alpha.-glucan polymer storage compartment and the method includes targeting said .alpha.-glucosidase enzyme activity to the .alpha.-glucan polymer storage compartment.
8. A method according to claim 7 wherein the .alpha.-glucan polymer storage compartment is an amyloplast.
9 A method according to any of claims 1 to 8 wherein the produced .alpha.-glucan has a branched .alpha.-glucan content of different nature from that of an equivalent cell in which the MOS content is not altered.
10. A method according to any of claims 1 to 9 wherein the .alpha.-glucan is starch.
11. A method according to any of claims 1 to 10 wherein the branched .alpha.-glucan is amylopectin.
12. A method according to any of claims 1 to 11 wherein the produced .alpha.-glucan is removed from the cell.
13. A method according to claim 12 wherein the .alpha.-glucan is purified.
14. A method according to any of claims 1 to 13 wherein the produced .alpha.-glucan is formulated into a composition.
15. An .alpha.-glucan producing plant cell having glucan synthase activity, transformed with nucleic acid encoding .alpha.-glucosidase enzyme activity, whereby the transformed plant cell expresses the .alpha.-glucosidase enzyme activity, which activity includes maltase activity but little or no iso-maltase activity and little or no activity against starch granules, and whereby the cellular malto-oligosaccharide (MOS) content is depleted and therefore the branched .alpha.-glucan content of the produced .alpha.-glucan is increased relative to its unbranched .alpha.-glucan content as compared with an equivalent cell having wild-type MOS level.
16. An .alpha.-glucan producing plant cell having glucan synthase activity, transformed with nucleic acid encoding enzyme activity, whereby the transformed plant cell expresses the enzyme activity, which activity generates malto-oligosaccharide (MOS) within the cell while having negligible activity against intact starch granules, and whereby the cellular MOS content is increased and therefore the unbranched .alpha.-glucan content of the produced .alpha.-glucan is increased relative to its branched .alpha.-glucan content as compared with its branched .alpha.-glucan content
17. A cell according to claim 16 wherein the enzyme activity comprises a disproportionating enzyme.
18. A cell according to claim 16 wherein the enzyme activity comprises a starch phosphorylase.
19. A cell according to claim 15 wherein said .alpha.-glucosidase enzyme activity is provided by a maltase of Bacillus amylolyticus or the maltase encoded by the MAL6 locus of Saccharromyces carlsbergensis or a mutant, derivative, variant or allele thereof.
20. A cell according to any of claims 15 to 19 wherein the .alpha.-glucan synthase activity is Granule Bound Starch Synthase I
(GBSSI) activity.
(GBSSI) activity.
21. A cell according to any of claims 15 to 20 wherein the cell has an .alpha.-glucan polymer storage compartment and said .alpha.-glucosidase enzyme activity is targeted to the .alpha.-glucan polymer storage compartment.
22. A cell according to claim 21 wherein the .alpha.-glucan polymer storage compartment is an amyloplast.
23. A cell according to any of claims 15 to 22 wherein the produced .alpha.-glucan has a branched .alpha.-glucan content of different nature from that of an equivalent cell in which the MOS content is not altered.
24. A cell according to any of claims 15 to 23 wherein the .alpha.-glucan is starch.
25. A cell according to any of claims 15 to 24 wherein the branched .alpha.-glucan is amylopectin.
26. A cell according to any of claims 15 to 25 which is comprised in a plant, a plant part or a plant propagule.
27 A method of producing a cell according to any of claims 15 to 26, the method including incorporating a heterologous nucleic acid having a sequence encoding for said enzyme activity into a plant cell.
28. A method according to claim 27 which includes recombining the heterologous nucleic acid with cellular genome nucleic acid such that it is stably incorporated therein.
29. A method according to claim 27 or claim 28 wherein the nucleic acid is introduced in the form of a vector.
30. A plant including a cell according to any one of claims 15 to 25.
31. A plant which is a sexually or asexually propagated off-spring, clone or descendant of a plant according to claim 30, or any part or propagule of said plant, off-spring, clone or descendant.
32. A part or propagule of a plant according to claim 31.
33. A method of producing a plant including .alpha.-glucan producing cells having .alpha.-glucan synthase activity wherein the produced .alpha.-glucan has increased branched .alpha.-glucan content, the method including incorporating a heterologous nucleic acid encoding .alpha.-glucosidase enzyme activity, which activity includes maltase activity but little or no iso-maltase activity and little or no activity against starch granules, into a plant cell and regenerating a plant from said plant cell, whereby the cellular malto-oligosaccharide (MOS) content in cells of the plant is depleted in cells expressing said .alpha.-glucosidase enzyme activity and therefore the branched .alpha.-glucan content of the produced .alpha.-glucan is increased relative to its unbranched .alpha.-glucan content as compared with an equivalent cell having wild-type MOS level.
34. A method of producing a plant including .alpha.-glucan producing cells having .alpha.-glucan synthase activity wherein the produced .alpha.-glucan has increased unbranched .alpha.-glucan content, the method including incorporating a heterologous nucleic acid encoding enzyme activity, which activity generates malto-oligosaccharide (MOS) within the cell while having negligible activity against intact starch granules, into a plant cell and regenerating a plant from said plant cell, whereby the cellular malto-oligosaccharide (MOS) content in cells of the plant is increased in cells expressing said enzyme activity and therefore the unbranched .alpha.-glucan content of the produced .alpha.-glucan is increased relative to its branched .alpha.-glucan content as compared with an equivalent cell having wild-type MOS level.
35. A method according to claim 34 wherein the enzyme activity comprises a disproportionating enzyme.
36. A method according to claim 34 wherein the enzyme activity comprises a starch phosphorylase.
37. A method according to any of claims 33 to 36 including sexually or asexually propagating or growing off-spring or a descendant of said plant.
38. A method of obtaining .alpha.-glucan, the method including removing .alpha.-glucan from a cell according to any of claims 15 to 26.
39. A method of obtaining .alpha.-glucan, the method including removing .alpha.-glucan from a plant, plant part or plant propagule according to any of claims 29 to 32.
40. A method according to claim 38 or claim 39 including purifying the .alpha.-glucan.
41. A method according to any of claims 38 to 40 including formulating the removed .alpha.-glucan into a composition.
42. A method according to any of claims 38 to 41 wherein the removed .alpha.-glucan is starch.
43. Use of alteration of the level of malto-oligosaccharide (MOS) in a plant cell for altering the content of unbranched and/or branched .alpha.-glucan produced in the plant cell.
44. Use according to claim 43 wherein the MOS level is altered in an .alpha.-glucan polymer storage compartment in the cell.
45. Use according to claim 44 wherein the .alpha.-glucan polymer storage compartment is an amyloplast.
46. Use according to any of claims 43 to 45 wherein the level of MOS is decreased and the .alpha.-glucan has reduced levels of unbranched .alpha.-glucan polymer.
47. Use according to any of claims 43 to 45 wherein the level of MOS is decreased and the .alpha.-glucan has a branched .alpha.-glucan content of different nature from that of an equivalent cell in which the MOS content is not altered.
48. Use according to any of claims 43 to 45 wherein the level of MOS is increased and the .alpha.-glucan has increased levels of unbranched .alpha.-glucan polymer.
49. Use according to any of claims 43 to 48 wherein the .alpha.-glucan produced in the plant cell is removed from the cell.
50. Use according to claim 49 wherein the .alpha.-glucan is purified.
51. Use according to any of claims 43 to 50 wherein the .alpha.-glucan is formulated into a composition.
52. Use according to any of claims 43 to 51 wherein the .alpha.-glucan is starch.
53. .alpha.-glucan produced by processing a cell, plant, or part or propagule of a plant provided or as claimed in any of claims 1 to 42.
54 .alpha.-glucan according to claim 53 which is starch.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9522589.2 | 1995-11-03 | ||
GBGB9522589.2A GB9522589D0 (en) | 1995-11-03 | 1995-11-03 | Modified plants and plant products |
PCT/GB1996/002696 WO1997016554A1 (en) | 1995-11-03 | 1996-11-04 | Modified plants and plant products |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2235619A1 true CA2235619A1 (en) | 1997-05-09 |
Family
ID=10783365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002235619A Abandoned CA2235619A1 (en) | 1995-11-03 | 1996-11-04 | Modified plants and plant products |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0871744A1 (en) |
JP (1) | JPH11514521A (en) |
AU (1) | AU720418B2 (en) |
CA (1) | CA2235619A1 (en) |
GB (1) | GB9522589D0 (en) |
WO (1) | WO1997016554A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9705746D0 (en) * | 1997-03-20 | 1997-05-07 | Spp | Food rheology improvements |
DE19836097A1 (en) | 1998-07-31 | 2000-02-03 | Hoechst Schering Agrevo Gmbh | Nucleic acid molecules coding for an alpha-glucosidase, plants that synthesize a modified starch, process for producing the plants, their use and the modified starch |
CN1528904B (en) * | 1998-08-19 | 2010-05-26 | 先进技术(剑桥)有限公司 | A novel plastid-directed nucleic acid sequence, a novel beta-amylase sequence, a stimulus-responsive promoter and uses thereof |
BR9915026A (en) | 1998-10-09 | 2001-07-17 | Planttec Biotechnologie Gmbh | Nucleic acid molecules encoding a branching enzyme from bacteria of the genus neisseria as well as methods for the production of alpha-1,4 glycans branched to alpha-1,6 |
CA2416632C (en) | 2000-08-28 | 2012-01-24 | E.I. Du Pont De Nemours And Company | Novel starches produced by the expression of heterologous granule bound starch synthase genes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989012386A1 (en) * | 1988-06-21 | 1989-12-28 | Calgene, Inc. | Methods and compositions for altering physical characteristics of fruit and fruit products |
DK198089D0 (en) * | 1989-04-24 | 1989-04-24 | Danske Spritfabrikker | DNA MATERIALS AND USE THEREOF |
JPH05507626A (en) * | 1990-06-11 | 1993-11-04 | カルジーン,インコーポレイティド | Cyclodextrin production in transgenic plants |
US5349123A (en) * | 1990-12-21 | 1994-09-20 | Calgene, Inc. | Glycogen biosynthetic enzymes in plants |
IE913215A1 (en) * | 1990-09-13 | 1992-02-25 | Gist Brocades Nv | Transgenic plants having a modified carbohydrate content |
GB9218185D0 (en) * | 1992-08-26 | 1992-10-14 | Ici Plc | Novel plants and processes for obtaining them |
WO1995004826A1 (en) * | 1993-08-09 | 1995-02-16 | Institut Für Genbiologische Forschung Berlin Gmbh | Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants |
US5750876A (en) * | 1994-07-28 | 1998-05-12 | Monsanto Company | Isoamylase gene, compositions containing it, and methods of using isoamylases |
-
1995
- 1995-11-03 GB GBGB9522589.2A patent/GB9522589D0/en active Pending
-
1996
- 1996-11-04 CA CA002235619A patent/CA2235619A1/en not_active Abandoned
- 1996-11-04 JP JP9517171A patent/JPH11514521A/en active Pending
- 1996-11-04 AU AU73239/96A patent/AU720418B2/en not_active Ceased
- 1996-11-04 EP EP96935165A patent/EP0871744A1/en not_active Withdrawn
- 1996-11-04 WO PCT/GB1996/002696 patent/WO1997016554A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1997016554A1 (en) | 1997-05-09 |
GB9522589D0 (en) | 1996-01-03 |
AU720418B2 (en) | 2000-06-01 |
JPH11514521A (en) | 1999-12-14 |
AU7323996A (en) | 1997-05-22 |
EP0871744A1 (en) | 1998-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6791010B1 (en) | Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications | |
JP4148964B2 (en) | DNA molecules encoding enzymes involved in starch synthesis, and vectors, bacteria, transgenic plant cells and transgenic plants containing the DNA molecules | |
AU740492C (en) | Novel nucleic acid molecules from maize and their use for the production of modified starch | |
US6794558B1 (en) | Nucleic acid module coding for αglucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch | |
EP1681352B1 (en) | Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis | |
JP4101304B2 (en) | Nucleic acid molecule encoding an enzyme having fructosyl polymerase activity | |
US7897760B2 (en) | Plants which synthesize a modified starch, process for the production thereof and modified starch | |
CA2214736A1 (en) | Modified starch from plants, plants synthesizing the same, as well as process for their production | |
JP3431177B2 (en) | Plasmids producing transgenic plants altered in habit and yield | |
AU697997B2 (en) | Production of trehalose in plants | |
AU720418B2 (en) | Modified plants and plant products | |
US7968766B2 (en) | Plant UDP-galatose epimerases | |
EP1131442B1 (en) | Genetically modified plants with altered starch | |
EP1235904B1 (en) | Fructose polymer synthesis in monocot plastids | |
AU3227300A (en) | Udp-glucose modifiers | |
EP1584688A2 (en) | Fructose polymer synthesis in monocot plastids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |